var title_f37_6_37984="Verrucous endocarditis in SLE";
var content_f37_6_37984=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F79709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F79709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Libman Sacks verrucous endocarditis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 235px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Verrucous endocarditis with valvular vegetations (arrows) in a 52-year-old woman with systemic lupus erythematosus who died of pneumonia and chronic interstitial pneumonitis. The vegetations had not been observed by echocardiography, although a cardiac murmur had been heard by auscultation. A cerebrovascular accident was also found at autopsy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Peter H Schur, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37984=[""].join("\n");
var outline_f37_6_37984=null;
var title_f37_6_37985="Morbilliform drug eruption";
var content_f37_6_37985=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F54205&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F54205&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Exanthematous (morbilliform) drug eruption",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Numerous erythematous macules and papules are present in this patient with a morbilliform drug eruption.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37985=[""].join("\n");
var outline_f37_6_37985=null;
var title_f37_6_37986="Indium In-111 oxyquinoline: Patient drug information";
var content_f37_6_37986=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Indium In-111 oxyquinoline: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?13/40/13955?source=see_link\">",
"     see \"Indium In-111 oxyquinoline: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F15070242\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915097",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used with a test to check for abscesses or infection.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F15070241\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915102",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have and allergy to indium 111 oxyquinolone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F15070243\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F15070244\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698344",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F15070245\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F15070281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F15070246\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 86619 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-190.111.122.2-5368725AE9-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37986=[""].join("\n");
var outline_f37_6_37986=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070242\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070241\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070243\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070244\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070245\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070281\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15070246\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?13/40/13955?source=related_link\">",
"      Indium In-111 oxyquinoline: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_6_37987="Patient information: Heart attack recovery (The Basics)";
var content_f37_6_37987=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/16327\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/38/42598\">",
"         Foods with fiber",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/15/1268\">",
"          Heart attack symptoms",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?20/34/21027\">",
"         Patient information: Chest pain (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/10/27809\">",
"         Patient information: Coronary heart disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?11/35/11827\">",
"         Patient information: Diet and health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/39/20083\">",
"         Patient information: Exercise (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?9/53/10068\">",
"         Patient information: Heart attack (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?33/58/34722\">",
"         Patient information: High blood pressure in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?10/48/11011\">",
"         Patient information: High cholesterol (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?21/27/21940\">",
"         Patient information: Medicines after a heart attack (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/46/18146\">",
"         Patient information: Quitting smoking (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/21/6483\">",
"         Patient information: Reducing the costs of medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?32/2/32803\">",
"         Patient information: What can go wrong after a heart attack? (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/54/40803\">",
"         Patient information: Aspirin and cardiovascular disease (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/16/40195\">",
"         Patient information: Heart attack (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?11/52/12100\">",
"         Patient information: Heart attack recovery (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?36/32/37380\">",
"         Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?6/4/6212\">",
"         Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?19/13/19670\">",
"         Patient information: Quitting smoking (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Heart attack recovery (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/heart-attack-recovery-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H29400745\">",
"      <span class=\"h1\">",
"       What happens after a heart attack?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After a heart attack, also called a myocardial infarction or MI, your doctor will make a treatment plan with you. The goal of this plan is to prevent another heart attack and lower your chance of dying from heart disease.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400752\">",
"      <span class=\"h1\">",
"       Do I need to take medicines?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Most people need to take more than 1 heart medicine every day. Doctors can prescribe different types of heart medicines. The ones you take will depend on your heart condition and how your heart attack was treated. Some heart medicines help prevent chest pain and other heart symptoms. Other heart medicines help prevent future heart attacks and help you live longer. To prevent another heart attack, you will probably need to take",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?6/12/6342?source=see_link\">",
"       aspirin",
"      </a>",
"      and possibly another medicine every day.",
"     </p>",
"     <p>",
"      If you have high blood pressure, high cholesterol, or diabetes (high blood sugar), your doctor will likely prescribe medicines to treat those conditions. Having untreated high blood pressure, high cholesterol, or diabetes can increase your chance of having another heart attack.",
"     </p>",
"     <p>",
"      It&rsquo;s important to take your medicines exactly the way your doctor says. Let your doctor or nurse know if you have any side effects or problems with the medicines. You should also let him or her know if you can&rsquo;t afford your medicines. There are often ways to solve these problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400759\">",
"      <span class=\"h1\">",
"       Do I need to make lifestyle changes?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You might. After a heart attack, your doctor or nurse will talk with you about:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Quitting smoking, if you smoke &mdash; Quitting smoking can lower your chance of getting or dying from heart disease. To stop smoking, some people find it helpful to:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Use nicotine patches, gum, or nasal sprays instead of cigarettes &mdash; Nicotine is the main drug found in cigarettes.",
"       </li>",
"       <li>",
"        Work with a counselor to find ways to make it easier to quit",
"       </li>",
"       <li>",
"        Take a prescription medicine to reduce cigarette cravings",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Getting exercise &mdash; Getting regular exercise can keep your heart healthy. Your doctor or nurse will suggest an exercise program that is safe for you. Most doctors recommend that people exercise 30 to 60 minutes a day, 5 or more days of the week. In your exercise program, you should include 3 main types of exercise:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        &ldquo;Aerobic exercise&rdquo; to raise your heart rate &mdash; Examples of aerobic exercise include walking, swimming, and jogging.",
"       </li>",
"       <li>",
"        &ldquo;Resistance training&rdquo; to make your muscles stronger &mdash; People can use weights or exercise bands to do these exercises.",
"       </li>",
"       <li>",
"        Stretching your muscles and joints",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Improving your diet &mdash; Eating the right foods can help keep you healthy. Fruits, vegetables, and foods with fiber can help prevent heart disease and strokes (",
"        <a class=\"graphic graphic_figure graphicRef79063 \" href=\"mobipreview.htm?41/38/42598\">",
"         figure 1",
"        </a>",
"        ). Try to avoid eating foods that can make heart disease worse. These include &ldquo;trans&rdquo; fats, which are found in many fast foods. &ldquo;Saturated&rdquo; fats, which are found in red meats and many cheeses, can also worsen heart disease. If you are overweight, it&rsquo;s important to lose weight. Losing extra weight lowers your chance of having another heart attack.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400766\">",
"      <span class=\"h1\">",
"       What is cardiac rehab?",
"      </span>",
"      &nbsp;&mdash;&nbsp;&ldquo;Cardiac rehab&rdquo; is the term doctors use for the care people receive after a heart attack. In your cardiac rehab program, doctors, nurses, and other health professionals will teach you how to keep your heart healthy. This includes ways to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Exercise safely",
"       </li>",
"       <li>",
"        Improve your diet, stop smoking, and control your other health conditions",
"       </li>",
"       <li>",
"        Cope with feeling sad or worried after your heart attack",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400773\">",
"      <span class=\"h1\">",
"       When can I have sex again?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Having sex during the first 2 weeks after a heart attack could lead to more heart trouble. Check with your doctor about when it is safe to start having sex again. The timing will depend on the size of your heart attack, if you had problems after your heart attack, and if you still have symptoms.",
"     </p>",
"     <p>",
"      After a heart attack, some people are less interested in sex or do not enjoy sex as much. This can be caused by certain heart medicines. It can also happen if people are worried about having a heart attack during sex. If you have problems with sex, let your doctor or nurse know. He or she might be able to treat those problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400780\">",
"      <span class=\"h1\">",
"       When can I drive again and return to work?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Check with your doctor about when it is safe for you to drive again and return to work. Most people can drive again 1 week after their heart attack. Many people can return to work within 2 weeks of having a heart attack.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400787\">",
"      <span class=\"h1\">",
"       What symptoms should I watch for?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After you have a heart attack, you should watch for chest pain or symptoms of another heart attack (",
"      <a class=\"graphic graphic_figure graphicRef52579 \" href=\"mobipreview.htm?1/15/1268\">",
"       figure 2",
"      </a>",
"      ). People who have a heart attack have a higher than normal chance of having another heart attack and other heart problems.",
"     </p>",
"     <p>",
"      If you think you might be having another heart attack,",
"      <strong>",
"       call 9-1-1 right away",
"      </strong>",
"      . Do not try to get to the hospital on your own.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H29400655\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/53/10068?source=see_link\">",
"       Patient information: Heart attack (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/27/21940?source=see_link\">",
"       Patient information: Medicines after a heart attack (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/34/21027?source=see_link\">",
"       Patient information: Chest pain (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/39/20083?source=see_link\">",
"       Patient information: Exercise (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/35/11827?source=see_link\">",
"       Patient information: Diet and health (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/58/34722?source=see_link\">",
"       Patient information: High blood pressure in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/48/11011?source=see_link\">",
"       Patient information: High cholesterol (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=see_link\">",
"       Patient information: Reducing the costs of medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/46/18146?source=see_link\">",
"       Patient information: Quitting smoking (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/10/27809?source=see_link\">",
"       Patient information: Coronary heart disease (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/2/32803?source=see_link\">",
"       Patient information: What can go wrong after a heart attack? (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=see_link\">",
"       Patient information: Heart attack recovery (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/16/40195?source=see_link\">",
"       Patient information: Heart attack (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/54/40803?source=see_link\">",
"       Patient information: Aspirin and cardiovascular disease (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/4/6212?source=see_link\">",
"       Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/13/19670?source=see_link\">",
"       Patient information: Quitting smoking (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=see_link\">",
"       Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?37/6/37987?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 16327 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1102-210.101.131.232-8FC26C7E2B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37987=[""].join("\n");
var outline_f37_6_37987=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400745\">",
"      What happens after a heart attack?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400752\">",
"      Do I need to take medicines?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400759\">",
"      Do I need to make lifestyle changes?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400766\">",
"      What is cardiac rehab?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400773\">",
"      When can I have sex again?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400780\">",
"      When can I drive again and return to work?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400787\">",
"      What symptoms should I watch for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29400655\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/16327\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/38/42598\">",
"      Foods with fiber",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/15/1268\">",
"       Heart attack symptoms",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/54/40803?source=related_link\">",
"      Patient information: Aspirin and cardiovascular disease (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?20/34/21027?source=related_link\">",
"      Patient information: Chest pain (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/10/27809?source=related_link\">",
"      Patient information: Coronary heart disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/35/11827?source=related_link\">",
"      Patient information: Diet and health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?19/39/20083?source=related_link\">",
"      Patient information: Exercise (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?39/16/40195?source=related_link\">",
"      Patient information: Heart attack (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?9/53/10068?source=related_link\">",
"      Patient information: Heart attack (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/52/12100?source=related_link\">",
"      Patient information: Heart attack recovery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?33/58/34722?source=related_link\">",
"      Patient information: High blood pressure in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/32/37380?source=related_link\">",
"      Patient information: High blood pressure treatment in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/48/11011?source=related_link\">",
"      Patient information: High cholesterol (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?6/4/6212?source=related_link\">",
"      Patient information: High cholesterol and lipids (hyperlipidemia) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?21/27/21940?source=related_link\">",
"      Patient information: Medicines after a heart attack (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?6/21/6483?source=related_link\">",
"      Patient information: Reducing the costs of medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?32/2/32803?source=related_link\">",
"      Patient information: What can go wrong after a heart attack? (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_6_37988="Trichothiodystrophy";
var content_f37_6_37988=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F87474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F87474&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Trichothiodystrophy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 576px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Short, brittle hair is characteristic of trichothiodystrophy.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37988=[""].join("\n");
var outline_f37_6_37988=null;
var title_f37_6_37989="Dexmedetomidine: Pediatric drug information";
var content_f37_6_37989=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dexmedetomidine: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?32/53/33622?source=see_link\">",
"    see \"Dexmedetomidine: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/52/34627?source=see_link\">",
"    see \"Dexmedetomidine: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F158352\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Precedex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F158353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Precedex&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1008230\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Adrenergic Agonist Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Alpha-Adrenergic Agonist",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Sedative",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1008260\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/53/33622?source=see_link\">",
"      see \"Dexmedetomidine: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Errors have occurred due to misinterpretation of dosing information. Maintenance dose expressed as mcg/kg/",
"     <b>",
"      <span style=\"text-decoration: underline\">",
"       hour",
"      </span>",
"     </b>",
"     .",
"     <b>",
"      Note:",
"     </b>",
"     Individualize and titrate to desired clinical effect: I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Children (limited data): Loading dose: 0.5-1 mcg/kg; followed by a maintenance infusion of 0.2-0.7 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; children &lt;1 year may require higher infusion rates; average infusion range: 0.4 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     vs 0.29 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     in children &gt;1 year; doses as high as 0.75 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     were used (Chrysostomou, 2006). Other studies have used maintenance doses as high as 1 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     (Munro, 2007; Nichols, 2005).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     ICU sedation: Initial: Loading dose: 1 mcg/kg, followed by a maintenance infusion of 0.2-0.7 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; adjust rate to desired level of sedation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Procedural sedation: Initial: Loading infusion of 1 mcg/kg [or 0.5 mcg/kg for less invasive procedures (eg, ophthalmic)] over 10 minutes, followed by a maintenance infusion of 0.6 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     , titrate to desired effect; usual range: 0.2-1 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fiberoptic intubation (awake): Initial: Loading infusion of 1 mcg/kg over 10 minutes, followed by a maintenance infusion of 0.7 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     until endotracheal tube is secured",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     The manufacturer does not recommend that the duration of infusion exceed 24 hours; however, there have been a few studies in adults demonstrating that dexmedetomidine was well tolerated in treatment periods &gt;24 hours; titrate infusion rate so patient awakens slowly; abrupt discontinuation, particularly after prolonged infusions may result in withdrawal symptoms.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Dosage reduction may need to be considered. No specific guidelines available.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F158336\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Precedex&reg;: 100 mcg/mL (2 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F158321\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1008265\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     I.V.: Administer using a controlled infusion device. Dilute 200 mcg (2 mL) in 48 mL NS to achieve a final concentration of 4 mcg/mL. Infuse loading dose over 10 minutes; rapid infusions are associated with severe side effects. Dexmedetomidine may adhere to natural rubber; use administration components made with synthetic or coated natural rubber gaskets.",
"    </p>",
"   </div>",
"   <div class=\"block uicp drugH1Div\" id=\"F14471306\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Usual Infusion Concentrations: Pediatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      I.V. infusion:",
"     </b>",
"     4 mcg/mL",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F158377\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, LR, NS, mannitol 20%, plasma substitute",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Alfentanil, amikacin, aminophylline, amiodarone, ampicillin, ampicillin/sulbactam, azithromycin, aztreonam, bumetanide, butorphanol, calcium gluconate, cefazolin, cefepime, cefotaxime, cefotetan, cefoxitin, ceftazidime, cefuroxime, chlorpromazine, cimetidine, ciprofloxacin, cisatracurium, clindamycin, dexamethasone sodium phosphate, digoxin, diltiazem, diphenhydramine, dobutamine, dolasetron, dopamine, doxycycline, droperidol, enalaprilat, ephedrine, epinephrine, erythromycin, esmolol, etomidate, famotidine, fenoldopam, fentanyl, fluconazole, furosemide, gentamicin, granisetron, haloperidol, heparin, hydrocortisone sodium succinate, hydromorphone, hydroxyzine, inamrinone, isoproterenol, ketorolac, labetalol, levofloxacin, lidocaine, linezolid, lorazepam, magnesium sulfate, meperidine, methylprednisolone sodium succinate, metoclopramide, metronidazole, milrinone, nalbuphine, nitroglycerin, nitroprusside, norepinephrine, ondansetron, piperacillin, piperacillin/tazobactam, potassium chloride, procainamide, prochlorperazine, promethazine, propofol, ranitidine, remifentanil, rocuronium, sodium bicarbonate, sufentanil, sulfamethoxazole/trimethoprim, theophylline, ticarcillin/clavulanate, tobramycin, vancomycin, verapamil.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amphotericin B, diazepam.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Ceftriaxone.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     May adsorb to certain types of natural rubber; use components made with synthetic or coated natural rubber gaskets whenever possible.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1008249\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store at room temperature; compatible when administered with LR, D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS, 20% mannitol, thiopental, etomidate, vecuronium, pancuronium, succinylcholine, atracurium, mivacurium, glycopyrrolate, phenylephrine, atropine, midazolam, morphine, and fentanyl  (see manufacturer&rsquo;s information for more extensive compatibility listings). Incompatible when administered with amphotericin B and diazepam.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     May adsorb to certain types of natural rubber; use components made with synthetic or coated natural rubber gaskets whenever possible.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1008231\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting; sedation prior to and/or during surgical or other procedures of nonintubated patients; duration of infusion should not exceed 24 hours. Other uses include premedication prior to anesthesia induction with thiopental; relief of pain and reduction of opioid dose following laparoscopic tubal ligation; as an adjunct anesthetic in ophthalmic surgery; treatment of shivering; premedication to attenuate the cardiostimulatory and postanesthetic delirium of ketamine. FDA approved in ages &ge;18 years.",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F158379\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Precedex&reg; may be confused with Peridex&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Errors have occurred due to misinterpretation of dosing information; use caution. Maintenance dose expressed as mcg/kg/",
"       <b>",
"        hour",
"       </b>",
"       .",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F158376\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Atrial fibrillation, bradycardia,hypotension, hypovolemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hypocalcemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea,  xerostomia",
"    </p>",
"    <p style=\"text-indent:-4em;margin-left:4em;margin-right:2em;text-align:justify;\">",
"     Renal: Urine output decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Pleural effusion, respiratory depression, wheezing",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Abdominal pain, abnormal vision, acidosis, agitation, alkaline phosphatase increased, ALT increased, anemia, apnea, arrhythmia, AST increased, atrioventricular block, BUN increased, bronchospasm, cardiac arrest, confusion, delirium, diaphoresis, diarrhea, dizziness, dyspnea, extrasystoles, fever, GGT increased, hallucination, headache, heart block, hemorrhage, hepatic impairment, hyperbilirubinemia, hypercapnia, hyperkalemia, hypertension, hypoglycemia, hypoventilation, hypoxia, illusion, MI, neuralgia, neuritis, oliguria, pain, photopsia, pulmonary congestion, respiratory acidosis, rigors, seizure, speech disorder, supraventricular tachycardia, tachycardia, thirst, T-wave inversion, ventricular arrhythmia, ventricular tachycardia, vomiting",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1008235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dexmedetomidine or any component; use outside of an intensive care setting",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F2890152\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Use with caution in patients with advanced heart block, severe ventricular dysfunction, hypovolemia, diabetes mellitus, and chronic hypertension. Use with caution in patients receiving vasodilators or drugs which decrease heart rate. Patients may be arousable and alert when stimulated. This alone should not be considered as lack of efficacy in the absence of other clinical signs/symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1008236\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Should be administered only by persons skilled in management of patients in intensive care setting or operating room. Patients should be continuously monitored. Episodes of bradycardia and sinus arrest have been associated with dexmedetomidine when administered rapidly I.V. (eg, bolus administration) or to patients with high vagal tone. Hypotension and bradycardia have been associated with dexmedetomidine infusion; treatment may include the use of atropine or glycopyrrolate, stopping or decreasing the infusion, increasing the rate of I.V. fluid administration, use of pressor agents, and elevation of the lower extremities. Transient hypertension has been primarily observed during the loading dose in association with the initial peripheral vasoconstrictive effects of dexmedetomidine. Treatment is usually unnecessary; however, reduction of infusion rate may be required.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Usage for &gt;24 hours is not recommended; abrupt discontinuation, if used for prolonged periods may result in withdrawal symptoms similar to those reported for another alpha",
"     <sub>",
"      2",
"     </sub>",
"     adrenergic agent, clonidine.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F158366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP2A6 (major);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak), CYP2C9 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F158330\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antidepressants (Alpha2-Antagonist): May diminish the antihypertensive effect of Alpha2-Agonists. Management: Consider avoiding concurrent use.  If these combinations cannot be avoided, monitor for decreased effects of alpha2-agonists if an alpha2-antagonist is initiated/dose increased, or increased effects if an alpha2-antagonist is discontinued/dose decreased.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Beta-Blockers: Alpha2-Agonists may enhance the AV-blocking effect of Beta-Blockers. Sinus node dysfunction may also be enhanced. Beta-Blockers may enhance the rebound hypertensive effect of Alpha2-Agonists. This effect can occur when the alpha",
"     <sub>",
"      2",
"     </sub>",
"     -agonist is abruptly withdrawn.  Management: Closely monitor heart rate during treatment with a beta blocker and clonidine. Withdraw beta blockers several days before clonidine withdrawal when possible, and monitor blood pressure closely. Recommendations for other alpha2-agonists are unavailable.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levobunolol; Metipranolol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2A6 Inhibitors (Moderate): May decrease the metabolism of CYP2A6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CYP2A6 Inhibitors (Strong): May decrease the metabolism of CYP2A6 Substrates.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypotensive Agents: May enhance the adverse/toxic effect of other Hypotensive Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Alpha2-Agonists may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the orthostatic hypotensive effect of Orthostatic Hypotension Producing Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May diminish the antihypertensive effect of Alpha2-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May diminish the antihypertensive effect of Alpha2-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F158332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6826804\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies. There are no adequate and well-controlled studies in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1008267\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Level of sedation, heart rate, respiration, ECG, blood pressure, pain control",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1008252\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Selective alpha",
"     <sub>",
"      2",
"     </sub>",
"     -adrenoceptor agonist similar to clonidine, but with a much higher affinity for alpha",
"     <sub>",
"      2",
"     </sub>",
"     -receptors over alpha",
"     <sub>",
"      1",
"     </sub>",
"     -receptors; alpha",
"     <sub>",
"      1",
"     </sub>",
"     activity was observed at high doses or after rapid infusions; produces &ldquo;arousable sedation&rdquo; in which patients experience clinically effective sedation yet are easily arousable. The sedative response exhibits properties similar to natural sleep specifically simulating NREM sleep. The sedative properties result primarily from its activity in the locus ceruleus of the brain stem. Analgesic effects are produced by stimulation of the alpha",
"     <sub>",
"      2",
"     </sub>",
"     -receptors in the dorsal horn of the spinal cord.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1008254\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      dss",
"     </sub>",
"     : Approximately 118 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: I.M.: 73%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 94%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via N-glucuronidation, N-methylation, and CYP2A6",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: Distribution: 6 minutes; Terminal: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: Urine (95%); feces (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance: Adults: 39 L/hour; hepatic impairment (Child-Pugh Class A, B, or C): mean clearance values were 74%, 64%, and 53% respectively, of those observed in healthy adults; clearance at birth is approximately 30% of adults, reaching adult values between 6-12 months of age",
"    </p>",
"   </div>",
"   <div class=\"block adi drugH1Div\" id=\"F2890154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Additional Information",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     As an adjunct to anesthesia, dexmedetomidine has been administered I.M. 0.5-1.5 mcg/kg/dose, 60 minutes prior to anesthesia.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Berkenbosch JW, Wankum PC, and Tobias JD, \"Prospective Evaluation of Dexmedetomidine for Noninvasive Procedural Sedation in Children,\"",
"      <i>",
"       Pediatr Crit Care Med",
"      </i>",
"      , 2005, 6(4):435-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Buck ML, \"Dexmedetomidine for Sedation in the Pediatric Intensive Care Setting,\"",
"      <i>",
"       Pedatr Pharm",
"      </i>",
"      , 2006, 12(1).",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chrysostomou C, Di Filippo S, Manrique AM, et al, \"Use of Dexmedetomidine in Children After Cardiac and Thoracic Surgery,\"",
"      <i>",
"       Pediatr Crit Care Med",
"      </i>",
"      , 2006, 7(2):126-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37989/abstract-text/16446599 /pubmed\" id=\"16446599 \" target=\"_blank\">",
"        16446599",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Munro HM, Tirotta CF, Felix DE, et al, \"Initial Experience With Dexmedetomidine for Diagnostic and Interventional Cardiac Catheterization in Children,\"",
"      <i>",
"       Paediatr Anaesth",
"      </i>",
"      , 2007, 17(2):109-12.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37989/abstract-text/17238880/pubmed\" id=\"17238880\" target=\"_blank\">",
"        17238880",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Nichols DP, Berkenbosch JW, and Tobias JD, \"Rescue Sedation With Dexmedetomidine for Diagnostic Imaging: A Preliminary Report,\"",
"      <i>",
"       Paediatr Anaesth",
"      </i>",
"      , 2005, 15(3):199-203.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37989/abstract-text/15725316/pubmed\" id=\"15725316\" target=\"_blank\">",
"        15725316",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Phan H and Nahata MC, \"Clinical Uses of Dexmedetomidine in Pediatric Patients,\"",
"      <i>",
"       Paediatr Drugs",
"      </i>",
"      , 2008, 10(1):49-69.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37989/abstract-text/18162008/pubmed\" id=\"18162008\" target=\"_blank\">",
"        18162008",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Walker J, Maccalum M, Fischer C, et al, \"Sedation Using Dexmedetomidine in Pediatric Burn Patients,\"",
"      <i>",
"       J Burn Care Res",
"      </i>",
"      , 2006, 27(2):206-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37989/abstract-text/16566567/pubmed\" id=\"16566567\" target=\"_blank\">",
"        16566567",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13128 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-218.28.111.102-5CC63B1F68-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37989=[""].join("\n");
var outline_f37_6_37989=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158352\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158353\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008230\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008260\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158336\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158321\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008265\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14471306\">",
"      Usual Infusion Concentrations: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158377\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008249\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008231\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158379\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158376\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008235\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2890152\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008236\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158366\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158330\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F158332\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6826804\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008267\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008252\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1008254\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2890154\">",
"      Additional Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13128\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13128|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?32/53/33622?source=related_link\">",
"      Dexmedetomidine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?33/52/34627?source=related_link\">",
"      Dexmedetomidine: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_6_37990="Overview of Peutz-Jeghers syndrome";
var content_f37_6_37990=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of Peutz-Jeghers syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/6/37990/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37990/contributors\">",
"     Anthony J Lembo, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/6/37990/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37990/contributors\">",
"     Paul Rutgeerts, MD, PhD, FRCP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/6/37990/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37990/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/6/37990/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 12, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peutz-Jeghers syndrome (PJS) is a condition in which multiple hamartomatous polyps are present in the gastrointestinal tract in association with distinctive mucocutaneous pigmentations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/1-3\">",
"     1-3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss the genetics, diagnosis, and the risk of malignancy in patients with PJS. Other familial syndromes characterized by the occurrence of hamartomatous polyps in the gastrointestinal tract (eg, juvenile polyposis, neurofibromatosis) are discussed separately [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/9/3224?source=see_link&amp;anchor=H21759704#H21759704\">",
"     \"Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families\", section on 'Juvenile polyposis syndrome and familial juvenile polyposis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32746?source=see_link\">",
"     \"Approach to the patient with colonic polyps\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peutz-Jeghers syndrome (PJS) was first recognized in 1921 by Peutz in a Dutch family; the pedigree of this family continues to be followed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. It is an autosomal dominant disorder with a high degree of penetrance for both polyposis and skin pigmentation as well as a 37 to 93 percent chance of cancer. Males and females are equally affected. It can occur in any racial or ethnic group. It is considered rare with prevalence estimates ranging between 1:25,000 and 1:280,000.",
"   </p>",
"   <p>",
"    The Peutz-Jeghers gene in most families has been mapped to chromosomal 19p13.3 close to marker D19S886 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. The defect in these families involves mutations in a gene encoding a serine threonine kinase (LKB1 or STK11); the germline mutations in this gene, probably in combination with acquired genetic defects of the second allele in somatic cells, are responsible for the clinical manifestations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. The role of this protein kinase is not known and PJS is the first cancer susceptibility syndrome shown to be due to inactivating mutations in a protein kinase. One possibility is that LKB1 functions as a tumor suppressor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    LKB1 also appears to regulate cell polarity, an observation that may be important for explaining how hamartomas develop and the apparent paradox that patients with PJS develop these benign polyps yet are predisposed to cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. A traditional theory has been that (for unclear reasons) some hamartomas in patients with PJS proceed on a pathway to malignant transformation. However, an alternative theory suggests that dysregulation of cell polarization leads concurrently to a cancer predisposition while also creating a predisposition for mucosal prolapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/13\">",
"     13",
"    </a>",
"    ]. Mucosal prolapse can lead to the development of polypoid lesions that are histologically similar to hamartomas. Thus, the hamartomas seen in PJS may be an epiphenomenon reflecting disruption of cell polarity pathways, which predisposes simultaneously to mucosal prolapse (and hamartoma formation) and cancer.",
"   </p>",
"   <p>",
"    Genetic testing is available at specialized laboratories (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Diagnosis'",
"    </a>",
"    below). However, mutations in LKB1 are detected in only 50 to 60 percent of families with PJS suggesting that there is a second PJS locus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/9\">",
"     9",
"    </a>",
"    ]. Three PJS families have been identified in which there was no linkage to 19p13.3; furthermore, none of the polyps from these families showed allele loss at D19S886 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two manifestations of Peutz-Jeghers syndrome (PJS): pigmented mucocutaneous macules and multiple hamartomatous gastrointestinal polyps, which are usually benign but may grow progressively and produce symptoms or undergo malignant transformation. In one series of 202 patients, the diagnosis was based upon the skin lesions in 52 patients and related to gastrointestinal polyps in 150 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Pigmented spots",
"    </span>",
"    &nbsp;&mdash;&nbsp;The characteristic mucocutaneous pigmentations (melanin spots) of PJS are present in more than 95 percent of patients and are caused by pigment laden macrophages in the dermis. They are typically flat, blue-gray to brown spots 1 to 5 mm in size that look like freckles. However, the onset and location of PJS spots is different than that of freckles.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      PJS lesions occur most commonly on the lips and perioral region (94 percent), hands (74 percent), buccal mucosa (66 percent) and feet (62 percent) (",
"      <a class=\"graphic graphic_picture graphicRef80815 \" href=\"mobipreview.htm?5/20/5455\">",
"       picture 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/14\">",
"       14",
"      </a>",
"      ]. They also occur on the nose, perianal area, and genitals, and are rarely found in the intestines. They usually occur during the first one to two years of life, increase in size and number over the ensuing years, and finally fade after puberty with the exception of those on the buccal mucosa.",
"     </li>",
"     <li>",
"      Freckles, in contrast, are typically sparse near the nostrils and mouth, are absent at birth, and never appear on the buccal mucosa.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Malignant degeneration of these lesions is extremely rare.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Gastrointestinal polyps",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal hamartomatous polyps are present in most patients with PJS. These polyps contain a proliferation of smooth muscle extending into the lamina propria in an arborization-like fashion; the overlying epithelium is normal (",
"    <a class=\"graphic graphic_picture graphicRef81889 graphicRef69268 \" href=\"mobipreview.htm?40/43/41658\">",
"     picture 2A-B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/15\">",
"     15",
"    </a>",
"    ]. At endoscopy, the polyps have no major distinguishing features, and may be sessile, pedunculated, or lobulated.",
"   </p>",
"   <p>",
"    One series found the following frequency and location of polyps in patients with PJS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Small intestine &ndash; 64 percent",
"     </li>",
"     <li>",
"      Colon &ndash; 64 percent",
"     </li>",
"     <li>",
"      Stomach &ndash; 49 percent",
"     </li>",
"     <li>",
"      Rectum &ndash; 32 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The number of polyps ranges from 1 to more than 20 per segment of bowel, although some patients have solitary lesions. The size of the polyps is also variable, ranging from 0.1 to more than 5 cm in diameter (",
"    <a class=\"graphic graphic_picture graphicRef67988 \" href=\"mobipreview.htm?0/22/354\">",
"     picture 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Polyps begin to grow in the first decade of life and most patients become symptomatic between the age of 10 and 30. About 50 percent of patients present due to symptoms, while the other 50 percent present due to an affected parent. Approximately 25 percent of patients will not have a family history of PJS. The following distribution of presenting gastrointestinal symptoms was noted in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/14\">",
"     14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Obstruction caused by intussusception or occlusion of the lumen by the polyp &ndash; 43 percent",
"     </li>",
"     <li>",
"      Abdominal pain caused by infarction &ndash; 23 percent",
"     </li>",
"     <li>",
"      Acute or chronic rectal bleeding caused by ulceration &ndash; 14 percent",
"     </li>",
"     <li>",
"      Extrusion of the polyp through the rectum &ndash; 7 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Up to 69 percent of patients experience an intussusception during their lifetime, most often in the small intestine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/14,16,17\">",
"     14,16,17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with PJS are at risk for multiple operations and postoperative complications. It has been suggested that a combined endoscopic and laparoscopic approach can be used to treat proximal small bowel intussusception, markedly reducing the need for repeated laparotomies in these patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Clinical criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peutz-Jeghers syndrome (PJS) &nbsp;is a clinical diagnosis that may be supported by genetic testing. The diagnosis was traditionally based upon clinical criteria proposed in 1987 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For individuals with a histopathologically confirmed hamartoma, a definite diagnosis of PJS requires two of the following three findings:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Family history consistent with autosomal dominant inheritance",
"     </li>",
"     <li>",
"      Mucocutaneous hyperpigmentation",
"     </li>",
"     <li>",
"      Small-bowel polyposis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    For individuals without histopathologic verification of hamartomatous polyps, a probable diagnosis of PJS can be made based on the presence of two of the three clinical criteria above.",
"   </p>",
"   <p>",
"    For individuals without a family history of PJS, diagnosis depends upon the presence of two or more histologically verified Peutz-Jeghers-type hamartomatous polyps.",
"   </p>",
"   <p>",
"    For individuals with a first-degree relative with PJS, presence of mucocutaneous hyperpigmentation is sufficient for presumptive diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Genetic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic testing is also available. However, as noted above, not all mutations associated with PJS have been identified. Thus, a negative genetic test does not exclude the diagnosis. Laboratories performing genetic testing for PJS include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Ohio State University Molecular Pathology Laboratory, Columbus, OH. Telephone: (614) 292-5484, Fax: (614) 292-7072, e-mail: prior-1@medctr.osu.edu",
"     </li>",
"     <li>",
"      GeneDx, Inc., Rockville, MD, Telephone: (301) 519-2100 ext 102, Fax: (301) 519-2892, e-mail: sherrib@genedx.com (",
"      <a class=\"external\" href=\"file://www.genedx.com/\">",
"       www.genedx.com/",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Northwick Park and St. Mark's Hospitals, Kennedy-Galton Centre, NW Thames Regional Genetics Service, Harrow, United Kingdom. Telephone: (+44) 20 8869 3188, Fax: (+44) 20 8869 3106, e-mail: s.j.payne@imperial.ac.uk. Testing is also available at several other centers in Europe (see",
"      <a class=\"external\" href=\"file://www.genetests.org/\">",
"       www.genetests.org",
"      </a>",
"      for a partial listing).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A detailed list of laboratories performing genetic testing can be obtained through the web site",
"    <a class=\"external\" href=\"file://www.genetest.org/\">",
"     www.genetest.org",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RISK OF MALIGNANCY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Peutz-Jeghers syndrome (PJS) is associated with an increased risk of gastrointestinal and nongastrointestinal malignancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. In a systematic review of 20 cohort studies which included 1644 patients with PJS, the reported lifetime risk for any cancer varied between 37 and 93 percent, with relative risks ranging from 10 to 18 in comparison with the general population [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/20\">",
"     20",
"    </a>",
"    ]. The average age of developing a malignancy was 42 years. The most common sites for malignancy were colorectal, followed by breast, stomach, small bowel, and pancreas.",
"   </p>",
"   <p>",
"    In a subsequent report of 133 patients with PJS, the cumulative cancer risk was 20 percent (gastrointestinal cancer 12 percent) at age 40 years and 76 percent (gastrointestinal cancer 51 percent) at age 70 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/22\">",
"     22",
"    </a>",
"    ]. The risk of cancer was higher in women than in men (hazard ratio 4.8). During 5004 person-years of follow-up there were 42 deaths, occurring at a mean age of 45 years. Two-thirds of the deaths were cancer-related.",
"   </p>",
"   <p>",
"    Follow-up of the original family described by Peutz revealed that only 17 of 22 affected family members survived into adulthood [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/5\">",
"     5",
"    </a>",
"    ]. The mean age of death for affected family members was substantially younger than for unaffected family members (38 versus 69 years). Causes of death included intestinal carcinoma, bowel obstruction, and extraintestinal cancers (breast and squamous-cell carcinoma of the nasal cavity).",
"   </p>",
"   <p>",
"    The overall incidence of cancer was estimated in a study of 240 individuals with known mutations in STK11 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/21\">",
"     21",
"    </a>",
"    ]. The overall risk of developing cancer at ages 20, 30, 40, 50, 60, and 70 was 1, 3, 19, 32, 63, and 81 percent, respectively. In women, the risk for breast cancer was substantially increased (32 percent by age 60).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Gastrointestinal cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because hamartomatous polyps are benign, they were initially not thought to represent a premalignant condition. However, the distribution of gastrointestinal cancers in these patients is similar to that of the hamartomatous polyps and carcinoma arising in hamartomas has been clearly documented [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/23-26\">",
"     23-26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the review noted above, the reported risk of gastrointestinal cancer was between 38 and 66 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/20\">",
"     20",
"    </a>",
"    ]. The most common sites were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Colorectal &ndash; 38 percent",
"     </li>",
"     <li>",
"      Stomach &ndash; 29 percent",
"     </li>",
"     <li>",
"      Small bowel &ndash; 13 percent",
"     </li>",
"     <li>",
"      Pancreas &ndash; 11 to 36 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Other gastrointestinal tumors that may occur in the PJS include cancers of the biliary tree and gallbladder and esophagus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/22,27,28\">",
"     22,27,28",
"    </a>",
"    ]. The reason for the increased risk of gastrointestinal cancer is uncertain. It does not appear to be due to increased oncogene expression, which is known to be involved in the adenoma-carcinoma sequence in colorectal cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=see_link\">",
"     \"Molecular genetics of colorectal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Nongastrointestinal cancers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of nongastrointestinal cancers is increased in both males and females with PJS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/19\">",
"     19",
"    </a>",
"    ]. In one series, for example, 26 cases of cancer developed in 18 of 34 (53 percent) patients; 16 of these 26 tumors were nongastrointestinal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/30\">",
"     30",
"    </a>",
"    ]. Another report summarized six publications with a total of 210 individuals with PJS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/28\">",
"     28",
"    </a>",
"    ]. The cumulative risk of cancer was 93 percent from age 15 to 64 years old. Extracolonic cancers accounted for 55 of the 66 malignancies (83 percent). Compared to population-based controls, the risk was increased for cancers of the lung, breast, uterus, and ovary.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Females have an increased incidence of gynecological cancers (13 to 18 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/20\">",
"       20",
"      </a>",
"      ]. The most common sites are breast (32 to 54 percent), ovary (21 percent), and cervix (10 percent). Cervical tumors include cervical adenoma malignum, a highly differentiated mucinous adenocarcinoma with a highly aggressive behavior [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/31\">",
"       31",
"      </a>",
"      ]. In addition, small, asymptomatic, benign ovarian tumors known as \"sex-cord\" tumors with annular tubules (SCTAT tumors) occur commonly in women with PJS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. These tumors are often associated with signs of hyperestrogenism which can lead to sexual precocity [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/32,33\">",
"       32,33",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8778?source=see_link\">",
"       \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Males appear to have an increased incidence of Sertoli cell testicular tumors (9 percent) that are often hormonally active [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/20,30,34\">",
"       20,30,34",
"      </a>",
"      ]. Some present with gynecomastia, rapid growth, and advanced bone age with markedly elevated levels of estradiol [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/40/5770?source=see_link&amp;anchor=H22#H22\">",
"       \"Anatomy and pathology of testicular tumors\", section on 'Sertoli cell tumors'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Issues of screening and surveillance are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/9/3224?source=see_link&amp;anchor=H21759653#H21759653\">",
"     \"Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families\", section on 'Screening and surveillance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     CHEMOPROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Effective methods of chemoprophylaxis to prevent formation of hamartomas and malignancies have not been established. Studies in mice have suggested a potential role for COX-2 inhibitors and rapamycin in prevention of hamartomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37990/abstract/36,37\">",
"     36,37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     PATIENT ADVOCACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several resources are available for patients and families with Peutz-Jeghers syndrome (PJS).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Support groups",
"    </span>",
"    &nbsp;&mdash;&nbsp;A list serve is available at:",
"    <a class=\"external\" href=\"file://listserv.acor.org/archives/pjs.html\">",
"     listserv.acor.org/archives/pjs.html",
"    </a>",
"    . Another support group is available at:",
"    <a class=\"external\" href=\"file://www.peutz-jeghers.com/\">",
"     www.peutz-jeghers.com",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Genetic counselors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Genetic counselors can be found through several web sites:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://www.cancer.gov/cancertopics/genetics/directory/description\">",
"       www.cancer.gov/cancertopics/genetics/directory/description",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.geneclinics.org/\">",
"       www.geneclinics.org",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.nsgc.org/\">",
"       www.nsgc.org",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peutz-Jeghers syndrome (PJS) is a condition in which multiple hamartomatous polyps are present in the gastrointestinal tract in association with distinctive mucocutaneous pigmentations and an increased risk for cancer. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PJS is an autosomal dominant disorder. It is considered rare with prevalence estimates ranging between 1:25,000 and 1:280,000. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Genetics'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two main clinical manifestations of PJS: pigmented mucocutaneous macules and multiple gastrointestinal polyps. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The characteristic mucocutaneous pigmentations (melanin spots) of PJS are present in more than 95 percent of patients, occurring most commonly on the lips and perioral region, hands, buccal mucosa, and feet.",
"     </li>",
"     <li>",
"      Gastrointestinal hamartomatous polyps are present in most patients with PJS and can occur anywhere in the GI tract. Polyps begin to grow in the first decade of life and most patients become symptomatic between the age of 10 and 30 years. The number of polyps ranges from 1 to more than 20 per segment of bowel.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of PJS is based upon specific clinical criteria for individuals with or without a histopathologically confirmed hamartoma, and for individuals with or without a family history of PJS. Genetic testing is also available; however, a negative genetic test does not exclude the diagnosis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      PJS is associated with an increased risk of gastrointestinal and nongastrointestinal cancers. The reported lifetime risk for any cancer varies between 37 and 93 percent, at an average age of 42 years. The most common sites of gastrointestinal tract malignancy are the colon and pancreas and the most common site of extraintestinal tract cancer is the breast. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Risk of malignancy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/1\">",
"      JEGHERS H, McKUSICK VA, KATZ KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 1949; 241:1031.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/2\">",
"      Peutz JL. Over een zeer merkwaardige, gecombineerde familiaire pollyposis van de sligmliezen van den tractus intestinalis met die van de neuskeelholte en gepaard met eigenaardige pigmentaties van huid-en slijmvliezen. Ned Maandschr v Gen 1921; 10:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/3\">",
"      JEGHERS H, McKUSICK VA, KATZ KH. Generalized intestinal polyposis and melanin spots of the oral mucosa, lips and digits; a syndrome of diagnostic significance. N Engl J Med 1949; 241:993, illust; passim.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/4\">",
"      Harned RK, Buck JL, Sobin LH. The hamartomatous polyposis syndromes: clinical and radiologic features. AJR Am J Roentgenol 1995; 164:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/5\">",
"      Westerman AM, Entius MM, de Baar E, et al. Peutz-Jeghers syndrome: 78-year follow-up of the original family. Lancet 1999; 353:1211.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/6\">",
"      Olschwang S, Markie D, Seal S, et al. Peutz-Jeghers disease: most, but not all, families are compatible with linkage to 19p13.3. J Med Genet 1998; 35:42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/7\">",
"      Jenne DE, Reimann H, Nezu J, et al. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/8\">",
"      Hemminki A, Markie D, Tomlinson I, et al. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 1998; 391:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/9\">",
"      Lim W, Hearle N, Shah B, et al. Further observations on LKB1/STK11 status and cancer risk in Peutz-Jeghers syndrome. Br J Cancer 2003; 89:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/10\">",
"      Boudeau J, Sapkota G, Alessi DR. LKB1, a protein kinase regulating cell proliferation and polarity. FEBS Lett 2003; 546:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/11\">",
"      Baas AF, Kuipers J, van der Wel NN, et al. Complete polarization of single intestinal epithelial cells upon activation of LKB1 by STRAD. Cell 2004; 116:457.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/12\">",
"      Martin SG, St Johnston D. A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature 2003; 421:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/13\">",
"      Jansen M, de Leng WW, Baas AF, et al. Mucosal prolapse in the pathogenesis of Peutz-Jeghers polyposis. Gut 2006; 55:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/14\">",
"      Utsunomiya J, Gocho H, Miyanaga T, et al. Peutz-Jeghers syndrome: its natural course and management. Johns Hopkins Med J 1975; 136:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/15\">",
"      Haggitt RC, Reid BJ. Hereditary gastrointestinal polyposis syndromes. Am J Surg Pathol 1986; 10:871.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/16\">",
"      Hinds R, Philp C, Hyer W, Fell JM. Complications of childhood Peutz-Jeghers syndrome: implications for pediatric screening. J Pediatr Gastroenterol Nutr 2004; 39:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/17\">",
"      van Lier MG, Mathus-Vliegen EM, Wagner A, et al. High cumulative risk of intussusception in patients with Peutz-Jeghers syndrome: time to update surveillance guidelines? Am J Gastroenterol 2011; 106:940.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/18\">",
"      Cunningham JD, Vine AJ, Karch L, Aisenberg J. The role of laparoscopy in the management of intussusception in the Peutz-Jeghers syndrome: case report and review of the literature. Surg Laparosc Endosc 1998; 8:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/19\">",
"      Giardiello FM, Welsh SB, Hamilton SR, et al. Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med 1987; 316:1511.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/20\">",
"      van Lier MG, Wagner A, Mathus-Vliegen EM, et al. High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations. Am J Gastroenterol 2010; 105:1258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/21\">",
"      Lim W, Olschwang S, Keller JJ, et al. Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology 2004; 126:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/22\">",
"      van Lier MG, Westerman AM, Wagner A, et al. High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut 2011; 60:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/23\">",
"      Perzin KH, Bridge MF. Adenomatous and carcinomatous changes in hamartomatous polyps of the small intestine (Peutz-Jeghers syndrome): report of a case and review of the literature. Cancer 1982; 49:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/24\">",
"      Settaf A, Mansori F, Bargach S, Saidi A. [Peutz-Jeghers syndrome with carcinomatous degeneration of a duodenal hamartomatous polyp]. Ann Gastroenterol Hepatol (Paris) 1990; 26:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/25\">",
"      Defago MR, Higa AL, Campra JL, et al. Carcinoma in situ arising in a gastric hamartomatous polyp in a patient with Peutz-Jeghers syndrome. Endoscopy 1996; 28:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/26\">",
"      Bujanda L, Beguiristain A, Villar JM, et al. [Gastric adenocarcinoma in hamartomatous polyp in Peutz-Jeghers syndrome]. Gastroenterol Hepatol 1996; 19:452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/27\">",
"      Rebsdorf Pedersen I, Hartvigsen A, Fischer Hansen B, et al. Management of Peutz-Jeghers syndrome. Experience with patients from the Danish Polyposis Register. Int J Colorectal Dis 1994; 9:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/28\">",
"      Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/29\">",
"      Entius MM, Westerman AM, Giardiello FM, et al. Peutz-Jeghers polyps, dysplasia, and K-ras codon 12 mutations. Gut 1997; 41:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/30\">",
"      Boardman LA, Thibodeau SN, Schaid DJ, et al. Increased risk for cancer in patients with the Peutz-Jeghers syndrome. Ann Intern Med 1998; 128:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/31\">",
"      Srivatsa PJ, Keeney GL, Podratz KC. Disseminated cervical adenoma malignum and bilateral ovarian sex cord tumors with annular tubules associated with Peutz-Jeghers syndrome. Gynecol Oncol 1994; 53:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/32\">",
"      Young RH, Dickersin GR, Scully RE. A distinctive ovarian sex cord-stromal tumor causing sexual precocity in the Peutz-Jeghers syndrome. Am J Surg Pathol 1983; 7:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/33\">",
"      Young RH, Welch WR, Dickersin GR, Scully RE. Ovarian sex cord tumor with annular tubules: review of 74 cases including 27 with Peutz-Jeghers syndrome and four with adenoma malignum of the cervix. Cancer 1982; 50:1384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/34\">",
"      Wilson DM, Pitts WC, Hintz RL, Rosenfeld RG. Testicular tumors with Peutz-Jeghers syndrome. Cancer 1986; 57:2238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/35\">",
"      Young S, Gooneratne S, Straus FH 2nd, et al. Feminizing Sertoli cell tumors in boys with Peutz-Jeghers syndrome. Am J Surg Pathol 1995; 19:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/36\">",
"      Udd L, Katajisto P, Rossi DJ, et al. Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology 2004; 127:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37990/abstract/37\">",
"      Wei C, Amos CI, Zhang N, et al. Suppression of Peutz-Jeghers polyposis by targeting mammalian target of rapamycin signaling. Clin Cancer Res 2008; 14:1167.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2533 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-30319E2B35-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37990=[""].join("\n");
var outline_f37_6_37990=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      GENETICS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Pigmented spots",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Gastrointestinal polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Clinical criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Genetic testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RISK OF MALIGNANCY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Gastrointestinal cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Nongastrointestinal cancers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      CHEMOPROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      PATIENT ADVOCACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Support groups",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Genetic counselors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2533\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2533|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?5/20/5455\" title=\"picture 1\">",
"      Peutz Jeghers oral lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?15/48/16137\" title=\"picture 2A\">",
"      PJS duodenal polyp Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?34/63/35833\" title=\"picture 2B\">",
"      PJS colonic polyp Light",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?0/22/354\" title=\"picture 3\">",
"      Peutz Jeghers colonic polyp",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/40/5770?source=related_link\">",
"      Anatomy and pathology of testicular tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32746?source=related_link\">",
"      Approach to the patient with colonic polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/33/30234?source=related_link\">",
"      Molecular genetics of colorectal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/9/3224?source=related_link\">",
"      Peutz-Jeghers syndrome and juvenile polyposis: Screening and management of patients and families",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8778?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_6_37991="Octreotide: Pediatric drug information";
var content_f37_6_37991=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Octreotide: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"    see \"Octreotide: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/31/18934?source=see_link\">",
"    see \"Octreotide: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F202953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      SandoSTATIN LAR&reg;;",
"     </li>",
"     <li>",
"      SandoSTATIN&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F202954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Octreotide Acetate Injection;",
"     </li>",
"     <li>",
"      Octreotide Acetate Omega;",
"     </li>",
"     <li>",
"      Sandostatin LAR&reg;;",
"     </li>",
"     <li>",
"      Sandostatin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1060641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidiarrheal",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antidote",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antihemorrhagics",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antisecretory Agent",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Somatostatin Analog",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block don drugH1Div\" id=\"F12675255\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Neonatal",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Chylothorax:",
"     </b>",
"     Continuous I.V. infusion: 0.3-10 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     titrated to response (median: 2.8 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ) has been described in case reports; treatment duration is usually 1-3 weeks but may vary with the clinical response (Das, 2010; Roehr, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Persistent hyperinsulinemic hypoglycemia of infancy",
"     </b>",
"     (Stanley, 1997):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Continuous I.V. infusion: Initial: 0.08-0.4 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ; titrate dosage depending upon patient response; maximum dose: 1.67 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     SubQ: Initial: 2-10 mcg/kg/day divided 3-4 times daily; titrate dosage depending upon patient response; maximum daily dose: 40 mcg/kg/day",
"    </p>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1060634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"      see \"Octreotide: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage should be individualized according to the patient's response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Sandostatin&reg;:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Infants and Children (data limited to small studies and case reports):",
"     <b>",
"      Note:",
"     </b>",
"     The following are effective dosing ranges for specific therapies: I.V., SubQ:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Diarrhea:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Continuous I.V. infusion: Initial: 1 mcg/kg bolus dose, followed by a continuous infusion of 1 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     has been used successfully in several cases of severe diarrhea secondary to graft vs host disease",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.V., SubQ: Doses of 1-10 mcg/kg/dose every 12 hours have been used in children beginning at the low end of the range and increasing based upon the clinical response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Chylothorax:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     Continuous I.V. infusion: 0.3-10 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     titrated to response (median: 2.8 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     ) has been described in case reports; treatment duration is usually 1-3 weeks but may vary with the clinical response (Roehr, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     SubQ: 40 mcg/kg/day; case reports of effective dosage range from 2-68 mcg/kg/day (Chan, 2006; Roehr, 2006)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Esophageal varices/GI bleed: 1-2 mcg/kg initial I.V. bolus followed by 1-2 mcg/kg/",
"     <b>",
"      hour",
"     </b>",
"     continuous infusion; titrate infusion rate to response; taper dose by 50% every 12 hours when no active bleeding occurs for 24 hours; may discontinue when dose is 25% of initial dose (Eroglu, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Hypothalamic obesity (from cranial insult): SubQ: 5 mcg/kg/day divided into 3 daily doses; dose may be increased bimonthly at 5 mcg/kg/day increments to a maximum of 15 mcg/kg/day divided into 3 daily doses (Lustig, 2003)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Persistent hyperinsulinemic hypoglycemia of infancy: SubQ: 2-10 mcg/kg/day divided 3-4 times daily; titrate dosage depending upon patient response; maximum daily dose: 40 mcg/kg/day (Stanley, 1997)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Treatment of sulfonylurea overdose:",
"     <b>",
"      Note:",
"     </b>",
"     SubQ is the preferred route of administration; repeat dosing, dose escalation, or initiation of a continuous infusion may be required in patients who experience recurrent hypoglycemia. Duration of treatment may exceed 24 hours. Optimal care decisions should be made based upon patient-specific details; SubQ: 1-1.5 mcg/kg/dose; repeat in 6-12 hours as needed based upon blood glucose concentrations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Acromegaly:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     SubQ, I.V.: Initial: 50 mcg 3 times/day; titrate to achieve growth hormone levels &lt;5 ng/mL or IGF-I (somatomedin C) levels &lt;1.9 units/mL in males and &lt;2.2 units/mL in females. Usual effective dose is 100-200 mcg 3 times/day; range: 300-1500 mcg/day.",
"     <b>",
"      Note:",
"     </b>",
"     Should be withdrawn yearly for a 4-week interval (8 weeks for depot injection) in patients who have received irradiation. Resume if levels increase and signs/symptoms recur.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.M. depot injection: Patients must be stabilized on subcutaneous octreotide for at least 2 weeks before switching to the long-acting depot. Upon switch: 20 mg I.M. intragluteally every 4 weeks for 3 months, then the dose may be modified based upon response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <i>",
"      Dosage adjustment:",
"     </i>",
"     After 3 months of depot injections, the dosage may be continued or modified as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     GH &le;1 ng/mL, IGF-1 normal, and symptoms controlled: Reduce octreotide LAR&reg; to 10 mg I.M. every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     GH &le;2.5 ng/mL, IGF-1 normal, and symptoms controlled: Maintain octreotide LAR&reg; at 20 mg I.M. every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     GH &gt;2.5 ng/mL, IGF-1 elevated, and/or symptoms uncontrolled: Increase octreotide LAR&reg; to 30 mg I.M. every 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients not adequately controlled at a dose of 30 mg may increase dose to 40 mg every 4 weeks. Dosages &gt;40 mg are not recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Carcinoid tumors:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     SubQ, I.V.: Initial 2 weeks: 100-600 mcg/day in 2-4 divided doses; usual range: 50-750 mcg/day (some patients may require up to 1500 mcg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.M. depot injection: Patients must be stabilized on subcutaneous octreotide for at least 2 weeks before switching to the long-acting depot. Upon switch: 20 mg I.M. intragluteally every 4 weeks for 2 months, then the dose may be modified based upon response",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients should continue to receive their SubQ injections for the first 2 weeks at the same dose in order to maintain therapeutic levels (some patients may require 3-4 weeks of continued SubQ injections). Patients who experience periodic exacerbations of symptoms may require temporary SubQ injections in addition to depot injections (at their previous SubQ dosing regimen) until symptoms have resolved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <i>",
"      Dosage adjustment:",
"     </i>",
"     See dosing adjustment for VIPomas.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     VIPomas:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     SubQ, I.V.: Initial 2 weeks: 200-300 mcg/day in 2-4 divided doses; titrate dose based on response/tolerance; range: 150-750 mcg/day (doses &gt;450 mcg/day are rarely required)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     I.M. depot injection: Patients must be stabilized on subcutaneous octreotide for at least 2 weeks before switching to the long-acting depot. Upon switch: 20 mg I.M. intragluteally every 4 weeks for 2 months, then the dose may be modified based upon response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     Patients receiving depot injection should continue to receive their SubQ injections for the first 2 weeks at the same dose in order to maintain therapeutic levels (some patients may require 3-4 weeks of continued SubQ injections). Patients who experience periodic exacerbations of symptoms may require temporary SubQ injections in addition to depot injections (at their previous SubQ dosing regimen) until symptoms have resolved.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:8em;text-align:justify;\">",
"     <i>",
"      Dosage adjustment:",
"     </i>",
"     After 2 months of depot injections, the dosage may be continued or modified as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Increase to 30 mg I.M. every 4 weeks if symptoms are inadequately controlled",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Decrease to 10 mg I.M. every 4 weeks, for a trial period, if initially responsive to 20 mg dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:10em;text-align:justify;\">",
"     Dosage &gt;30 mg is not recommended",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in renal impairment:",
"     </b>",
"     Clearance is decreased by 50% in patients with severe renal failure requiring dialysis; consider dosage modification in these patients as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Nondialysis-dependent renal impairment: No dosage adjustment required",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Dialysis-dependent renal impairment: Depot injection: Initial dose: I.M.: 10 mg every 4 weeks; titrate based upon response (clearance is reduced by ~50%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment in hepatic impairment:",
"     </b>",
"     Patients with established cirrhosis of the liver: Depot injection: Initial dose: I.M.: 10 mg every 4 weeks; titrate based upon response",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F202929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, microspheres for suspension [depot formulation]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SandoSTATIN LAR&reg;: 10 mg, 20 mg, 30 mg [contains polylactide-co-glycolide; supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution: 100 mcg/mL (1 mL); 200 mcg/mL (5 mL); 1000 mcg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SandoSTATIN&reg;: 200 mcg/mL (5 mL); 1000 mcg/mL (5 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [preservative free]: 50 mcg/mL (1 mL); 100 mcg/mL (1 mL); 500 mcg/mL (1 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SandoSTATIN&reg;: 50 mcg/mL (1 mL); 100 mcg/mL (1 mL); 500 mcg/mL (1 mL)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F202915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes depot formulation",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1060645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Parenteral: Only Sandostatin&reg; injection may be administered I.V. and SubQ; Sandostatin LAR&reg; Depot may only be administered I.M.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     SubQ: Use the concentration with smallest volume to deliver dose to reduce injection site pain; rotate injection site; may bring to room temperature prior to injection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V. infusion: Dilute Sandostatin&reg; injection in 50-200 mL NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W and infuse over 15-30 minutes or over 24 hours as a continuous infusion; in emergency situations, may be administered undiluted by direct I.V. push over 3 minutes; allow solution to come to room temperature before administration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.M. administration: Reconstitute with provided diluent; see detailed instruction booklet for complete instructions; use immediately after reconstitution; administer into gluteal area only (avoid deltoid injections due to significant pain and discomfort at injection site)",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F203008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Solution: Stable in D",
"     <sub>",
"      5",
"     </sub>",
"     W, NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with fat emulsion 10%;",
"     <b>",
"      variable stability",
"     </b>",
"     in TPN (The manufacturer states that octreotide solution is not compatible in TPN solutions due to the formation of a glycosyl octreotide conjugate which may have decreased activity; other sources assign limited compatibility.)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration:",
"     </b>",
"     <b>",
"      Compatible:",
"     </b>",
"     Levofloxacin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Micafungin.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Pantoprazole, TPN.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Incompatible:",
"     </b>",
"     Dimenhydrinate, pantoprazole.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1060637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store in refrigerator between 2&deg;C and 8&deg;C (36&deg;F and 46&deg;F); protect from light; Sandostatin&reg; injection at room temperature at 20&deg;C to 30&deg;C (68&deg;F and 86&deg;F) and protected from light is stable for 14 days; parenteral admixtures are stable in NS for 4 days and D",
"     <sub>",
"      5",
"     </sub>",
"     W for 24 hours at room temperature; stable for up to 7 days in a polypropylene syringe; not compatible in TPN solutions due to glycosyl octreotide conjugate which may have decreased activity. Sandostatin LAR&reg; Depot must be used immediately after reconstitution",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1060644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Control of symptoms, including secretory diarrhea in patients with metastatic carcinoid or vasoactive intestinal peptide-secreting tumors (VIPomas) (FDA approved in adults); treatment of acromegaly (FDA approved in adults). Other uses include control of bleeding of esophageal varices, Cushing's syndrome, insulinomas, glucagonoma, small bowel fistulas, postgastrectomy dumping syndrome, chemotherapy-induced diarrhea, graft-versus-host disease (GVHD)-associated diarrhea, Zollinger-Ellison syndrome, persistent hyperinsulinemic hypoglycemia of infancy (nesidioblastosis), postoperative chylothorax, second-line treatment for thymic malignancies; islet cell tumors; treatment of malignant bowel obstruction; treatment of sulfonylurea overdosage (nondepot formulation); hypothalamic obesity",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F203010\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Octreotide may be confused with pasireotide",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       SandoSTATIN&reg; may be confused with SandIMMUNE&reg;, SandoSTATIN LAR&reg;, sargramostim, simvastatin",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F4370122\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse reactions vary by route of administration or dosage form.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cardiovascular: Angina, arrhythmia, cardiac failure, chest pain (non-depot formulations), conduction abnormalities, edema, flushing, hematoma, hypertension, palpitation, peripheral edema, phlebitis, sinus bradycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Central nervous system: Abnormal gait, amnesia, anxiety, confusion, depression, dizziness, dysphonia, fatigue, fever, hallucinations, headache, hypoesthesia, insomnia, malaise, nervousness, neuralgia, neuropathy, pain, somnolence, tremor, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Dermatologic: Acne, alopecia, bruising, cellulitis, pruritus, rash (depot formulation)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Breast pain, cachexia, goiter (non-depot formulations), gout, hyper-/hypoglycemia, hypokalemia, hypoproteinemia, hypothyroidism (non-depot formulations), impotence",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, biliary duct dilatation, biliary sludge (length of therapy dependent), cholelithiasis (length of therapy dependent), colitis, constipation, cramping, dehydration, diarrhea, diverticulitis, dyspepsia, dysphagia, fat malabsorption, feces discoloration, flatulence, gastritis, gastroenteritis, gingivitis, glossitis, loose stools, melena, nausea, steatorrhea, stomatitis, taste perversion, tenesmus, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Genitourinary: Incontinence, pollakiuria (non-depot formulations), urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Hematologic: Anemia (more common with depot formulations)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Local: Injection site hematoma/pain (dose and formulation related)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, arthropathy, back pain, hyperkinesia, hypertonia, joint pain, myalgia, neuropathy, paresthesia, rigors, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Ocular: Blurred vision, visual disturbance",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Otic: Earache, tinnitus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Renal: Albuminuria, renal abscess, renal calculus",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Respiratory: Bronchitis, cough, dyspnea (non-depot formulations), epistaxis, pharyngitis, rhinitis, sinusitis, upper respiratory infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Miscellaneous: Allergy, antibodies to octreotide, bacterial infection, cold symptoms, diaphoresis, flu symptoms, moniliasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Amenorrhea, anaphylactic shock, anaphylactoid reactions, aneurysm, aphasia, appendicitis, arthritis, ascending cholangitis, ascites, atrial fibrillation, basal cell carcinoma, Bell's palsy, biliary obstruction, breast carcinoma, cardiac arrest, cerebral vascular disorder, CHF, cholecystitis, cholestatic hepatitis, CK increased, deafness, diabetes insipidus, diabetes mellitus, fatty liver, galactorrhea, gallbladder polyp, GI bleeding, GI hemorrhage, GI ulcer, glaucoma, gynecomastia, hematuria, hepatitis, hypoadrenalism, hypoxia (children), intestinal obstruction, intracranial hemorrhage, intraocular pressure increased, ischemia, joint effusion, malignant hyperpyrexia, MI, migraine, necrotizing enterocolitis (neonates), nephrolithiasis, neuritis, oligomenorrhea, orthostatic hypotension, pancreatitis, pancytopenia, paresis, pituitary apoplexy, pleural effusion, pneumonia, pneumothorax, polymenorrhea, pulmonary embolism, pulmonary hypertension, pulmonary nodule, Raynaud&rsquo;s syndrome, renal failure, renal insufficiency, retinal vein thrombosis, seizures, status asthmaticus, suicide attempt, syncope, tachycardia, thrombocytopenia, thrombophlebitis, thrombosis, weight loss",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1060649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to octreotide or any component",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1060633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypothyroidism, with or without goiter, has been reported in acromegalic patients; use with caution in patients with renal impairment and consider dosage modification in patients with severe renal failure requiring dialysis; use with caution in patients with hepatic impairment; dosage adjustment required in patients with established cirrhosis; use caution in diabetic patients with gastroparesis; chronic usage is associated with abnormal Schillings test and depressed vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     levels; monitor vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     levels in patients receiving long-term therapy; suppression of growth hormone (animal data) is of concern when used as long-term therapy in children. Use with caution in patients with heart failure or concomitant medications that alter heart rate or rhythm; bradycardia, conduction abnormalities, and arrhythmia have been observed in acromegalic and carcinoid syndrome patients; cardiovascular medication requirements may change; may enhance the adverse/toxic effects of other QT",
"     <sub>",
"      c",
"     </sub>",
"     -prolonging agents. Vehicle used in depot injectable (polylactide-co-glycolide microspheres) has rarely been associated with retinal artery occlusion in patients with abnormal arteriovenous anastomosis.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1060632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage adjustment may be required to maintain symptomatic control; octreotide may affect glucose regulation; insulin requirements may be reduced in type I diabetic patients; symptomatic hypoglycemia which may be severe, has been reported; in nondiabetics and type II diabetics with partially intact insulin reserves, octreotide may decrease insulin levels and hyperglycemia may occur; monitor glucose tolerance and antidiabetic treatment closely; may worsen hypoglycemia in patients with insulinomas; patients must be monitored closely for biliary tract abnormalities (including biliary obstruction, cholecystitis, and cholelithiasis). The incidence of gallbladder stone or sludge increases with a duration of therapy &ge;12 months; reported incidence in children is ~33%. In patients with neuroendocrine tumors, the NCCN guidelines (v.2.2009) recommend considering prophylactic cholecystectomy in patients undergoing abdominal surgery if octreotide treatment is planned. Postmarketing cases of serious and fatal events, including hypoxia and necrotizing enterocolitis, have been reported with octreotide use in children (usually with serious underlying conditions), particularly in children &lt;2 years of age. In studies with octreotide depot, the incidence of cholelithiasis in children is higher than the reported incidences for adults.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F202924\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Codeine: Somatostatin Analogs may decrease the metabolism of Codeine. The formation of two major codeine metabolites (morphine and norcodeine) may be impaired by somatostatin analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CycloSPORINE (Systemic): Somatostatin Analogs may decrease the serum concentration of CycloSPORINE (Systemic).",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Herbs (Hypoglycemic Properties): May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Highest Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Highest Risk QTc-Prolonging Agents.  Management: Avoid such combinations when possible.  Use should be accompanied by close monitoring for evidence of QT prolongation or other alterations of cardiac rhythm.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hypoglycemic Agents: May enhance the adverse/toxic effect of other Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Loop Diuretics: May diminish the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     MAO Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mifepristone: May enhance the QTc-prolonging effect of QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying). Management: Though the drugs listed here have uncertain QT-prolonging effects, they all have some possible association with QT prolongation and should generally be avoided when possible.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Moderate Risk QTc-Prolonging Agents: QTc-Prolonging Agents (Indeterminate Risk and Risk Modifying) may enhance the QTc-prolonging effect of Moderate Risk QTc-Prolonging Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pegvisomant: Somatostatin Analogs may enhance the adverse/toxic effect of Pegvisomant. Specifically, this combination may increase the risk for significant elevations of liver enzymes.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Salicylates: May enhance the hypoglycemic effect of Hypoglycemic Agents.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: May enhance the hypoglycemic effect of Hypoglycemic Agents. Selective Serotonin Reuptake Inhibitors may increase the serum concentration of Hypoglycemic Agents. Management: Consider increased monitoring of glycemic control with concomitant use of a hypoglycemic agent and an SSRI. Dosage adjustments of the hypoglycemic agent may be necessary upon SSRI initiation or discontinuation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F1060651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Food Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Schedule injections between meals to decrease GI effects; may decrease vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     levels and decrease absorption of dietary fats. Avoid hypoglycemic herbs that may enhance the hypoglycemic effect of octreotide, including alfalfa, aloe, bilberry, bitter melon, burdock, celery, damiana, fenugreek, garcinia, garlic, ginger, ginseng, gymnema, marshmallow, and stinging nettle.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F202926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F1791383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal studies. Octreotide crosses the human placenta; data concerning use in pregnancy is limited. Women of childbearing potential should use adequate contraception during treatment with octreotide; normalization of IGF-1 and GH may restore fertility in women with acromegaly. In case reports of acromegalic women who received normal doses of octreotide during pregnancy, no congenital malformations were reported.",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1060640\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Baseline and periodic ultrasound evaluations for cholelithiasis, blood sugar, baseline and periodic thyroid function tests, fluid and electrolyte balance, fecal fat, and serum carotene determinations; for carcinoid, monitor urinary 5-hydroxyindole acetic acid (5-HIAA), plasma serotonin, plasma substance P; for VIPoma, monitor VIP; vitamin B",
"     <sub>",
"      12",
"     </sub>",
"     levels (chronic therapy); for acromegaly: growth hormone levels, IGF-I (somatomedin C), glycemic control, and antidiabetic regimen (patients with diabetes mellitus)",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F1060643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Vasoactive intestinal peptide (VIP): &lt;75 ng/L; levels vary considerably between laboratories; growth hormone level: &lt;5 ng/mL; IGF-I (somatomedin C): males: &lt;1.9 units/mL, females: &lt;2.2 units/mL",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1060631\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     A synthetic polypeptide which mimics natural somatostatin by inhibiting serotonin release, and the secretion of gastrin, vasoactive intestinal peptide (VIP), insulin, glucagon, secretin, motilin, thyrotropin, cholecystokinin, serotonin, and pancreatic polypeptide; in animals, also a potent inhibitor of growth hormone; decreases GI motility and inhibits intestinal secretion of water and electrolytes, and decreases splanchnic blood flow",
"    </p>",
"   </div>",
"   <div class=\"block phd drugH1Div\" id=\"F1060647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Duration (immediate release formulation): SubQ: 6-12 hours",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1060648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: SubQ: Rapid; I.M. (depot formulation): Released slowly (via microsphere degradation in the muscle)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: SubQ: 100%; I.M.: 60% to 63% of SubQ dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 13.6 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults with acromegaly: 21.6 &plusmn; 8.5 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 65% primarily to lipoprotein (41% in acromegaly)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Extensive by the liver",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life: 1.7-1.9 hours; up to 3.7 hours with cirrhosis; up to 3.4 hours with fatty liver disease; up to 3.1 hours in renal impairment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: SubQ: 0.4 hours (0.7 hours acromegaly); I.M.: 1 hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Elimination: 32% excreted unchanged in urine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Clearance:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults: 10 L/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Adults with acromegaly: 18 L/hour",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     When using Sandostatin LAR&reg; Depot formulation, steady-state levels are achieved after 3 injections (3 months of therapy)",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1060639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/31/18934?source=see_link\">",
"      see \"Octreotide: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May cause dry mouth",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Beckman RA, Siden R, Yanik GA, et al, &ldquo;Continuous Octreotide Infusion for the Treatment of Secretory Diarrhea Caused by Acute Intestinal Graft-Versus-Host Disease in a Child,&rdquo;",
"      <i>",
"       J Pediatr Hematol Oncol",
"      </i>",
"      , 2000, 22(4):344-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/10959906/pubmed\" id=\"10959906\" target=\"_blank\">",
"        10959906",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Calello DP, Osterhoudt KC, Henretig FM, et al, \"Octreotide for Pediatric Sulfonylurea Overdose: Review of 5 Cases,\"",
"      <i>",
"       Clin Toxicol",
"      </i>",
"      , 2005, 43:671.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chan SY, Lau W, Wong WH, et al, \"Chylothorax in Children After Congenital Heart Surgery,\"",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2006, 82(5):1650-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/17062221/pubmed\" id=\"17062221\" target=\"_blank\">",
"        17062221",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Cheung Y, Leung MP, and Yip M, &ldquo;Octreotide for Treatment of Postoperative Chylothorax,&rdquo;",
"      <i>",
"       J Pediatr",
"      </i>",
"      , 2001, 139(1):157-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/11445812/pubmed\" id=\"11445812\" target=\"_blank\">",
"        11445812",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Couper RT, Berzen A, Berall G, et al, &ldquo;Clinical Response to the Long-Acting Somatostatin Analogue SMS 201-995 in a Child With Congenital Microvillus Atrophy,&rdquo;",
"      <i>",
"       Gut",
"      </i>",
"      , 1989, 30(7):1020-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/2759484/pubmed\" id=\"2759484\" target=\"_blank\">",
"        2759484",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Das A and Shah PS, \"Octreotide for the Treatment of Chylothorax in Neonates,\"",
"      <i>",
"       Cochrane Database Syst Rev",
"      </i>",
"      , 2010, 9:CD006388.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/20824848/pubmed\" id=\"20824848\" target=\"_blank\">",
"        20824848",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Eroglu Y, Emerick KM, Whitingon PF, et al, \"Octreotide Therapy for Control of Acute Gastrointestinal Bleeding in Children,\"",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 2004, 38(1):41-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/14676593/pubmed\" id=\"14676593\" target=\"_blank\">",
"        14676593",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fasano CJ, O'Malley G, Dominici P, et al, \"Comparison of Octreotide and Standard Therapy Versus Standard Therapy Alone for the Treatment of Sulfonylurea-Induced Hypoglycemia,\"",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2008, 51(4):400-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/17764782/pubmed\" id=\"17764782\" target=\"_blank\">",
"        17764782",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Jaros W, Biller J, Greer S, et al, &ldquo;Successful Treatment of Idiopathic Secretory Diarrhea of Infancy With the Somatostatin Analogue SMS 201-995,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1988, 94(1):189-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/2891583/pubmed\" id=\"2891583\" target=\"_blank\">",
"        2891583",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Katz MD and Erstad BL, &ldquo;Octreotide, A New Somatostatin Analogue,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1989, 8(4):255-73.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/2653711 /pubmed\" id=\"2653711 \" target=\"_blank\">",
"        2653711",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kalomenidis I, \"Octreotide and chylothorax,\" Curr Opin Pulm Med, 2006, 12(4):264-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/16825878/pubmed\" id=\"16825878\" target=\"_blank\">",
"        16825878",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lugassy DM, Nelson LS, Hoffman RS, et al, \"Failure of Standard Octreotide Dosing to Prevent Recurrent Hypoglycemia Following Sulfonylurea Exposure in a Child,\"",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 2009, 47(7):760.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lustig RH, Hinds PS, Ringwald-Smith K, et al, \"Octreotide Therapy of Pediatric Hypothalamic Obesity: A Double-Blind, Placebo-Controlled Trial,\"",
"      <i>",
"       J Clin Endocrinol Metab",
"      </i>",
"      , 2003, 88(6):2586-92.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/12788859/pubmed\" id=\"12788859\" target=\"_blank\">",
"        12788859",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      McLaughlin SA, Crandall CS, and McKinney PE, \"Octreotide: An Antidote for Sulfonylurea-Induced Hypoglycemia,\"",
"      <i>",
"       Ann Emerg Med",
"      </i>",
"      , 2000, 36(2):133-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/10918104/pubmed\" id=\"10918104\" target=\"_blank\">",
"        10918104",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mordel A, Sivilotti ML, Old AC, et al, \"Octreotide for Pediatric Sulfonylurea Poisoning,\"",
"      <i>",
"       J Toxicol Clin Toxicol",
"      </i>",
"      , 1998, 36(5):437.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Pratap U, Slavik Z, Ofoe VD, et al, &ldquo;Octreotide to Treat Postoperative Chylothorax After Cardiac Operations in Children,&rdquo;",
"      <i>",
"       Ann Thorac Surg",
"      </i>",
"      , 2001, 72(5):1740-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/11722081 /pubmed\" id=\"11722081 \" target=\"_blank\">",
"        11722081",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roehr CC, Jung A, Proquitt&eacute; H, et al, \"Somatostatin or Octreotide as Treatment Options for Chylothorax in Young Children: A Systematic Review,\"",
"      <i>",
"       Intensive Care Med",
"      </i>",
"      , 2006, 32(5):650-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/16532329/pubmed\" id=\"16532329\" target=\"_blank\">",
"        16532329",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Siafakas C, Fox VL, and Nurko S, &ldquo;Use of Octreotide for the Treatment of Severe Gastrointestinal Bleeding in Children,&rdquo;",
"      <i>",
"       J Pediatr Gastroenterol Nutr",
"      </i>",
"      , 1998, 26(3):356-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/ 9523876 /pubmed\" id=\" 9523876 \" target=\"_blank\">",
"        9523876",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Stanley CA, &ldquo;Hyperinsulinism in Infants and Children,&rdquo;",
"      <i>",
"       Pediatr Clin North Am",
"      </i>",
"      , 1997, 44(2):363-74.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/ 9130925 /pubmed\" id=\" 9130925 \" target=\"_blank\">",
"        9130925",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tang J and Weiter JJ, \"Branch Retinal Artery Occlusion After Injection of a Long-Acting Risperidone Preparation,\"",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 2007, 147(4):283-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?37/6/37991/abstract-text/17709768/pubmed\" id=\"17709768\" target=\"_blank\">",
"        17709768",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12655 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-7EC3A6EE76-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37991=[""].join("\n");
var outline_f37_6_37991=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202953\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202954\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060641\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12675255\">",
"      Dosing: Neonatal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060634\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202929\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202915\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060645\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203008\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060637\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060644\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203010\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4370122\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060649\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060633\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060632\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299780\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202924\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060651\">",
"      Food Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F202926\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1791383\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060640\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060643\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060631\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060647\">",
"      Pharmacodynamics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060648\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1060639\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12655\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/12655|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=related_link\">",
"      Octreotide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?18/31/18934?source=related_link\">",
"      Octreotide: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_6_37992="Endometrial carcinoma: Clinical features and diagnosis";
var content_f37_6_37992=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Endometrial carcinoma: Clinical features and diagnosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Lee-may Chen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Jonathan S Berek, MD, MMS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Barbara Goff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?37/6/37992/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?37/6/37992/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 10, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1267574\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Worldwide in 2008, 287,100 women were diagnosed with uterine cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/1\">",
"     1",
"    </a>",
"    ]. The mortality rate was 1.7 to 2.4 per 100,000 women. In the United States, as with other developed countries, uterine cancer was the most common gynecologic malignancy, with approximately 46,470 new cases and 8120 deaths from the disease in 2011 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Adenocarcinoma of the endometrium (lining of the uterus) is the most common histologic site and type of uterine cancer.",
"   </p>",
"   <p>",
"    Abnormal uterine bleeding is the cardinal symptom of endometrial cancer. Occasionally, women with endometrial cancer who have no abnormal uterine bleeding present with abnormal findings on cervical cytology. Seventy-five to 90 percent of women with endometrial carcinoma present with abnormal uterine bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Sixty-eight percent of women with endometrial cancer are diagnosed with disease confined to the uterus and have a 96 percent five-year survival rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The clinical features, diagnosis, and screening of women for endometrial cancer will be reviewed here. An overview of endometrial cancer can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/7/21624?source=see_link\">",
"     \"Overview of endometrial carcinoma\"",
"    </a>",
"    .) Related topics are discussed in detail separately, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Histopathology and pathogenesis (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36983?source=see_link\">",
"       \"Endometrial carcinoma: Histopathology and pathogenesis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Epidemiology and risk factors (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=see_link\">",
"       \"Endometrial carcinoma: Epidemiology and risk factors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Staging and surgical treatment (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18810?source=see_link\">",
"       \"Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Adjuvant therapy (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/41/8855?source=see_link\">",
"       \"Approach to adjuvant treatment of endometrial cancer\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H336595\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial carcinoma typically presents with abnormal uterine bleeding and is most common in women who are postmenopausal and with increasing age in premenopausal women. Occasionally, women with no abnormal uterine bleeding present with abnormal findings on cervical cytology. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=see_link&amp;anchor=H1#H1\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281205\">",
"    <span class=\"h2\">",
"     Abnormal uterine bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suspicion of the presence of endometrial neoplasia (neoplastic endometrial hyperplasia or carcinoma) depends upon symptoms, age, and the presence of risk factors. Abnormal uterine bleeding is present in approximately 75 to 90 percent of women with endometrial carcinoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. The amount of bleeding does not correlate with the risk of cancer.",
"   </p>",
"   <p>",
"    For different patient populations, the following bleeding patterns should prompt endometrial evaluation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Postmenopausal women",
"      </strong>",
"      &ndash; Any bleeding, including spotting or staining. Three to 20 percent of women with postmenopausal bleeding are found to have endometrial carcinoma and another 5 to 15 percent have endometrial hyperplasia [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/3,7-9\">",
"       3,7-9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Age 45 to menopause",
"      </strong>",
"      &ndash; Any abnormal uterine bleeding, including intermenstrual bleeding in women who are ovulatory, frequent (interval between the onset of bleeding episodes is less than 21 days), heavy (total volume of &gt;80 mL), or prolonged (longer than seven days). In addition, endometrial neoplasia should be suspected in women with prolonged periods of amenorrhea (six or more months) in women with anovulation. Among cases of endometrial carcinoma, 19 percent occur in women aged 45 to 54 years compared with 6 percent in those aged 35 to 44 years [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Younger than 45 years",
"      </strong>",
"      &ndash; Abnormal uterine bleeding that is persistent, occurs in the setting of a history of unopposed estrogen exposure (obesity, chronic anovulation) or failed medical management of the bleeding, or in women at high risk of endometrial cancer (eg, Lynch syndrome) (",
"      <a class=\"graphic graphic_table graphicRef62089 \" href=\"mobipreview.htm?38/30/39403\">",
"       table 1",
"      </a>",
"      ). &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Use of 45 years old as the threshold for increased concern regarding endometrial neoplasia is supported by evidence that the risk of endometrial hyperplasia and carcinoma is fairly low prior to age 45 and increases with advancing age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/6,11\">",
"     6,11",
"    </a>",
"    ]. This age threshold is also consistent with American College of Obstetricians and Gynecologists guidelines issued [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/12\">",
"     12",
"    </a>",
"    ]. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26535?source=see_link&amp;anchor=H507038#H507038\">",
"     \"Classification and diagnosis of endometrial hyperplasia\", section on 'Epidemiology'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=see_link&amp;anchor=H1#H1\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\", section on 'Epidemiology'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Overall, the majority of abnormal uterine bleeding is due to benign conditions. However, given the risk of endometrial neoplasia, abnormal uterine bleeding, especially postmenopausal bleeding, requires further evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/24/23944?source=see_link\">",
"     \"Terminology and evaluation of abnormal uterine bleeding in premenopausal women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/41/2711?source=see_link\">",
"     \"Postmenopausal uterine bleeding\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281213\">",
"    <span class=\"h2\">",
"     Cervical cytology findings",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some cervical cytology findings are associated with endometrial neoplasia. Women with the following findings on cervical cytology require evaluation for endometrial neoplasia: &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Adenocarcinoma",
"      </strong>",
"      &ndash; Adenocarcinoma is sometimes seen on cervical cytology. Since the malignant cells may arise from either the cervix or endometrium, further evaluation with cervical and endometrial biopsy is required.",
"     </li>",
"     <li>",
"      <strong>",
"       Atypical glandular cells",
"      </strong>",
"      &ndash; Atypical glandular cells detected by cervical cytology should be investigated with an endometrial (and endocervical) biopsy to determine whether an endometrial neoplasm is the cause. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9624?source=see_link\">",
"       \"Cervical cytology: Evaluation of atypical and malignant glandular cells\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Endometrial cells",
"      </strong>",
"      &ndash; The presence of endometrial cells on cervical cytology is reported in the results in women &ge;40 years of age. The appearance of normal endometrial cells on cytology in asymptomatic premenopausal women is rarely associated with pathology and no further work-up is required [",
"      <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/13\">",
"       13",
"      </a>",
"      ]. Symptomatic or high risk women still require evaluation as appropriate. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=see_link&amp;anchor=H17#H17\">",
"       \"Cervical cytology: Interpretation of results\", section on 'Benign-appearing endometrial cells in a woman &ge;40 years'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1601978\">",
"    <span class=\"h2\">",
"     Incidental finding at hysterectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial carcinoma or hyperplasia is sometimes discovered incidentally when hysterectomy is performed for benign disease. Prior to hysterectomy, all women with abnormal uterine bleeding should have endometrial sampling. Preoperative diagnosis of endometrial neoplasia aids surgical planning.",
"   </p>",
"   <p>",
"    If metastatic disease in encountered intraoperatively, management depends upon the experience level of the surgeon. Intraoperative consultation from a gynecologic oncologist should be requested if available. Staging procedures performed by a gynecologic oncologist appear to lead to better patient outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/14\">",
"     14",
"    </a>",
"    ]. If a gynecologic oncologist is not available and a surgeon is not experienced in operative management of the cancer (eg, lymphadenectomy), it is prudent to close the patient and arrange for prompt consultation with a specialist for a second procedure.",
"   </p>",
"   <p>",
"    If endometrial carcinoma or hyperplasia is discovered after pathology evaluation of the hysterectomy specimen, the patient should be managed as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/7/21624?source=see_link&amp;anchor=H110435224#H110435224\">",
"     \"Overview of endometrial carcinoma\", section on 'Staging and treatment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/3/37943?source=see_link\">",
"     \"Management of endometrial hyperplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281523\">",
"    <span class=\"h1\">",
"     EVALUATION OF WOMEN WITH SUSPECTED ENDOMETRIAL NEOPLASIA",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281532\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with a clinical presentation suspicious for endometrial carcinoma or hyperplasia should undergo a pelvic examination to evaluate the size, mobility, and axis of the uterus. The information gained also helps the examiner to avoid complications during endometrial sampling (eg, uterine perforation). The examination may detect a pelvic mass, although women with endometrial hyperplasia or early stage endometrial carcinoma do not typically have an enlarged uterus. An enlarged, fixed uterus may be consistent with uterine leiomyomas or pelvic malignancy, and warrants further evaluation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/131?source=see_link&amp;anchor=H392000#H392000\">",
"     \"Endometrial sampling procedures\", section on 'General procedure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, pelvic examination helps to confirm that the source of the bleeding is the uterus and identify other possible etiologies of abnormal uterine bleeding (eg, uterine fibroids). It also aids surgical planning, if surgical evaluation or treatment is indicated. Either a large or fixed uterus may make hysterectomy more difficult and may influence the choice of surgical route (eg, abdominal, laparoscopic). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26535?source=see_link&amp;anchor=H507988#H507988\">",
"     \"Classification and diagnosis of endometrial hyperplasia\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281540\">",
"    <span class=\"h2\">",
"     Laboratory evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women of reproductive age with suspected endometrial hyperplasia or carcinoma should have urine or serum human chorionic gonadotropin testing to exclude pregnancy as an etiology of abnormal uterine bleeding and to ensure that endometrial sampling will not disrupt a pregnancy.",
"   </p>",
"   <p>",
"    Measurement of the hematocrit or clotting studies is necessary only if uterine bleeding is heavy and anemia or a coagulopathy are suspected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11305?source=see_link&amp;anchor=H6#H6\">",
"     \"Managing an episode of severe or prolonged uterine bleeding\", section on 'Evaluate for anemia and coagulopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281548\">",
"    <span class=\"h2\">",
"     Pelvic sonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women with suspected endometrial carcinoma or hyperplasia, pelvic sonography is often the first line imaging study to evaluate for other etiologies of abnormal uterine bleeding (eg, uterine leiomyomas).",
"   </p>",
"   <p>",
"    In postmenopausal women, transvaginal ultrasound evaluation of the endometrial thickness may be used as an initial study to evaluate for endometrial neoplasia in selected women. For these women, it is reasonable to defer endometrial sampling if the endometrial thickness is &lt;4 mm. This approach is an alternative to endometrial sampling, which is the gold standard for evaluation for endometrial neoplasia. However, if a woman continues to have bleeding even with an endometrial stripe of &lt;4 mm, a biopsy should be performed.",
"   </p>",
"   <p>",
"    In premenopausal women with suspected endometrial neoplasia, sonographic measurement of endometrial thickness",
"    <strong>",
"     cannot",
"    </strong>",
"    be used as an alternative to endometrial sampling. Use of ultrasound to evaluate the endometrium is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link&amp;anchor=H7#H7\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\", section on 'Transvaginal ultrasound'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1054261619\">",
"    <span class=\"h2\">",
"     Endometrial sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial sampling is usually performed with an office endometrial biopsy, which can be performed in an outpatient setting with no anesthesia or local anesthesia and is the least invasive approach. Office-based endometrial biopsy techniques, particularly the Pipelle device, are highly effective at diagnosing endometrial hyperplasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/131?source=see_link&amp;anchor=H1478865#H1478865\">",
"     \"Endometrial sampling procedures\", section on 'Office sampling versus dilation and curettage'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/131?source=see_link\">",
"     \"Endometrial sampling procedures\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some clinical situations, office endometrial biopsy should be followed with a dilation and curettage (D&amp;C). (See",
"    <a class=\"local\" href=\"#H282576\">",
"     'Negative endometrial sampling'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Surgeons may choose to perform D&amp;C as the initial procedure in some women. This includes women who cannot tolerate an office biopsy, those with heavy bleeding (D&amp;C is both a diagnostic and therapeutic procedure), and those who have a very high risk of endometrial cancer (eg, women with Lynch syndrome). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/41/35480?source=see_link\">",
"     \"Dilation and curettage\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11305?source=see_link&amp;anchor=H19#H19\">",
"     \"Managing an episode of severe or prolonged uterine bleeding\", section on 'Uterine curettage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some surgeons perform hysteroscopy with D&amp;C to ensure that focal lesions are identified and biopsied. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link&amp;anchor=H5#H5\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\", section on 'Hysteroscopy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1268005\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endometrial carcinoma is a histologic diagnosis made based upon the results of evaluation of an endometrial biopsy, curettage sample, or hysterectomy specimen. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14509188\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of endometrial carcinoma or hyperplasia includes other conditions that present with abnormal uterine bleeding. Women with presumed uterine bleeding should be evaluated to confirm that the source of the blood is the uterus, and not another part of the genital tract or the anus or rectum. The etiologies of uterine bleeding and other sources of genital tract bleeding are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35113?source=see_link\">",
"     \"Overview of causes of genital tract bleeding in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, for women who present with abnormal finding on cervical cytology, the differential diagnosis includes benign endometrium and cervical neoplasia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=see_link&amp;anchor=H17#H17\">",
"     \"Cervical cytology: Interpretation of results\", section on 'Benign-appearing endometrial cells in a woman &ge;40 years'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9624?source=see_link&amp;anchor=H16564920#H16564920\">",
"     \"Cervical cytology: Evaluation of atypical and malignant glandular cells\", section on 'Risk of premalignant or malignant disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282567\">",
"    <span class=\"h1\">",
"     FURTHER EVALUATION AFTER ENDOMETRIAL SAMPLING",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282576\">",
"    <span class=\"h2\">",
"     Negative endometrial sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensitivity for endometrial sampling is 90 percent or higher. Risk factors for false negative endometrial sampling include a personal history of colorectal cancer, endometrial polyps, and morbid obesity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282585\">",
"    <span class=\"h3\">",
"     Office endometrial biopsy with insufficient endometrial cells",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with an endometrial biopsy result that has insufficient endometrial cells should have sampling repeated with an office biopsy or dilation and curettage (D&amp;C). If two office endometrial biopsies have been unsuccessful, a D&amp;C should be performed. Cervical stenosis, a common cause of an unsuccessful biopsy, can be managed with preprocedure cervical preparation or dilation. Ultrasound guidance may be useful to aid endometrial sampling in some women. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/131?source=see_link&amp;anchor=H391920#H391920\">",
"     \"Endometrial sampling procedures\", section on 'Cervical preparation and dilation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282593\">",
"    <span class=\"h3\">",
"     Persistent or recurrent bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;If bleeding persists or recurs after endometrial sampling with benign findings, further evaluation is required. In our practice, we reevaluate such cases after three to six months.",
"   </p>",
"   <p>",
"    Abnormal uterine bleeding symptoms may be due to an etiology other than endometrial neoplasia. Transvaginal ultrasound, sonohysterography, or diagnostic hysteroscopy should be performed to exclude structural lesions (leiomyomas, endometrial polyp). Any structural lesions that are found should be treated, as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32601?source=see_link\">",
"     \"Hysteroscopic myomectomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/10/7336?source=see_link&amp;anchor=H1500838#H1500838\">",
"     \"Endometrial polyps\", section on 'Choosing a management approach'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to evaluation for structural lesions, it is essential to repeat endometrial sampling to exclude endometrial hyperplasia or carcinoma. Reported rates of endometrial neoplasia in women evaluated for persistent or recurrent postmenopausal bleeding vary widely, from 4 to 21 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/9,16\">",
"     9,16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282601\">",
"    <span class=\"h2\">",
"     Positive endometrial sampling",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H383882\">",
"    <span class=\"h3\">",
"     Staging and treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with endometrial carcinoma should undergo staging and treatment, as appropriate. Alternatively, endometrial hyperplasia may be diagnosed. Management of endometrial carcinoma and hyperplasia are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18810?source=see_link\">",
"     \"Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/41/8855?source=see_link\">",
"     \"Approach to adjuvant treatment of endometrial cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/3/37943?source=see_link\">",
"     \"Management of endometrial hyperplasia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It should be noted that an endometrial tumor may be undergraded when grading is based on sampling procedures rather than hysterectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. A higher grade may be assigned in as many as 30 percent of cases when the hysterectomy specimen is reviewed. The grade assigned by the endometrial sample alone is important mainly for women who are incompletely surgically staged or inoperable. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18810?source=see_link&amp;anchor=H6650587#H6650587\">",
"     \"Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment\", section on 'Controversies in lymph node assessment'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/41/8855?source=see_link&amp;anchor=H215732934#H215732934\">",
"     \"Approach to adjuvant treatment of endometrial cancer\", section on 'Inoperable patients'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H383853\">",
"    <span class=\"h3\">",
"     Postmenopausal women not on hormone therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Development of endometrial hyperplasia or carcinoma in a woman who is postmenopausal and should be estrogen-deficient requires further evaluation. In the absence of other sources of estrogen (eg, estrogen therapy, obesity), such women require evaluation for an estrogen-producing tumor (sex-cord stromal or germ cell tumors) (",
"    <a class=\"graphic graphic_table graphicRef55817 \" href=\"mobipreview.htm?24/4/24653\">",
"     table 2",
"    </a>",
"    ). We evaluate these women with serum estradiol and estrone concentrations. In postmenopausal women, normal concentrations are: unconjugated estradiol &le;20",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (73",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    and estrone &le;5.5",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (204",
"    <span class=\"nowrap\">",
"     pmol/L);",
"    </span>",
"    values may vary by laboratory.",
"   </p>",
"   <p>",
"    If estrogen levels are highly elevated, ultrasound of the adrenal glands and ovaries may be used to evaluate for a possible estrogen-secreting tumor. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8778?source=see_link&amp;anchor=H13#H13\">",
"     \"Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors\", section on 'Diagnosis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/37/5721?source=see_link&amp;anchor=H6#H6\">",
"     \"Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis\", section on 'Diagnosis overview'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If the concentrations are normal, we attempt to determine if other estrogenic medications, herbs, or creams have been used by the patient. As an example, unopposed ethinyl estradiol may cause endometrial hyperplasia, but this would not be detected in an estradiol or estrone assay because the antibodies used in these immunoassays would not crossreact with the ethinyl estradiol molecule. This is also true for some of the estrogens that are contained in creams.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1241219\">",
"    <span class=\"h3\">",
"     Women with risk factors for Lynch syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with Lynch syndrome (hereditary nonpolyposis colorectal cancer) have a lifetime risk of endometrial cancer of 27 to 71 percent, compared with 3 percent in the general population (",
"    <a class=\"graphic graphic_table graphicRef52285 \" href=\"mobipreview.htm?19/25/19869\">",
"     table 3",
"    </a>",
"    ). For women with endometrial cancer, the Society of Gynecologic Oncologists advises genetic assessment for Lynch syndrome for those who meet any of the following criteria (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18810?source=see_link&amp;anchor=H19#H19\">",
"     \"Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment\", section on 'Testing of tumor specimen for mismatch repair deficiency'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endometrial cancer diagnosed prior to age 50.",
"     </li>",
"     <li>",
"      Presence of synchronous or metachronous colorectal, or other Lynch-associated tumors, regardless of age.",
"     </li>",
"     <li>",
"      Endometrial cancer with tumor infiltrating lymphocytes, peritumoral lymphocytes, or undifferentiated tumor histology, lower uterine segment origin diagnosed in a patient less than age 60.",
"     </li>",
"     <li>",
"      One or more first-degree relatives with a Lynch-associated tumor, with one of the cancers being diagnosed under age 50.",
"     </li>",
"     <li>",
"      Endometrial or colorectal cancer diagnosed in two or more first-or second degree relatives with Lynch-associated tumors regardless of age.",
"     </li>",
"     <li>",
"      Patients with a first or second degree relative with a known mismatch repair gene.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Testing for Lynch syndrome is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/59/19386?source=see_link\">",
"     \"Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1268037\">",
"    <span class=\"h1\">",
"     ENDOMETRIAL CANCER SCREENING",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest",
"    <strong>",
"     not",
"    </strong>",
"    performing routine screening for endometrial carcinoma for most women. Women with Lynch syndrome (hereditary non-polyposis colon cancer) have a markedly increased risk of endometrial cancer and should undergo screening, and ultimately, risk-reducing hysterectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1268046\">",
"    <span class=\"h2\">",
"     Women at average or increased risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine screening of asymptomatic women at average or increased risk of endometrial carcinoma is not advised. There are no high quality data to support the efficacy of screening at reducing endometrial cancer mortality. &nbsp;",
"   </p>",
"   <p>",
"    This recommendation includes women with risk factors for endometrial cancer, with the exception of women with Lynch syndrome. Regarding",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    , a known risk factor for endometrial carcinoma, there are no expert recommendations for routine uterine cancer screening for asymptomatic patients. Any abnormal bleeding in a patient on tamoxifen warrants further evaluation. This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/38/41576?source=see_link&amp;anchor=H94636198#H94636198\">",
"     \"Managing the side effects of tamoxifen\", section on 'Screening for uterine tumors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Endometrial carcinoma has several characteristics that inform the recommendation against routine screening. As noted above, 75 to 90 percent of women with endometrial carcinoma present with abnormal uterine bleeding [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/3-5\">",
"     3-5",
"    </a>",
"    ]. Sixty-eight percent of women with endometrial cancer are diagnosed with disease confined to the uterus and have a 96 percent five-year survival rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/6\">",
"     6",
"    </a>",
"    ]. Thus for this disease, the presence of early symptoms provides secondary prevention, detecting a condition when treatment can stop it from progressing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/46/34537?source=see_link\">",
"     \"Evidence-based approach to prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early symptoms result in detection of most but not all cases of endometrial carcinoma at an early stage. However, another barrier to screening for this condition is that there is not screening test that is sensitive, specific, and acceptable to patients and physicians.",
"   </p>",
"   <p>",
"    While some women with endometrial carcinoma present with abnormal findings on cervical cytology, this is not an effective screening test for this disease. The sensitivity of conventional Pap smear for endometrial carcinoma is 40 to 55 percent; the sensitivity of liquid-based preparations is higher, 60 to 65 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Endometrial biopsy is a sensitive and specific test, but it is uncomfortable and invasive. The thickness of the endometrium on transvaginal sonography is also a sensitive test for detecting endometrial cancer in postmenopausal women; however, sensitivity is estimated to be 20 percent lower in asymptomatic compared to symptomatic women and specificity is low (the false positive rate is high); thus many women would end up needing an endometrial biopsy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link&amp;anchor=H3255342#H3255342\">",
"     \"Evaluation of the endometrium for malignant or premalignant disease\", section on 'Asymptomatic women with endometrial thickening or fluid'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This recommendation is consistent with advice from the American Cancer Society, which suggests that women at average or increased risk of developing endometrial cancer (except those with Lynch syndrome) be informed about their risks of developing the disease, educated about its symptoms (especially any unexpected bleeding) at the onset of menopause, and strongly encouraged to report such symptoms to their health care provider promptly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=see_link\">",
"     \"Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H282996\">",
"    <span class=\"h2\">",
"     Women with Lynch syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with Lynch syndrome (hereditary nonpolyposis colorectal cancer) have a lifetime risk of endometrial cancer of 27 to 71 percent, compared with 3 percent in the general population (",
"    <a class=\"graphic graphic_table graphicRef52285 \" href=\"mobipreview.htm?19/25/19869\">",
"     table 3",
"    </a>",
"    ). Strategies for screening and prevention of endometrial cancer in these women include endometrial sampling and risk-reducing hysterectomy.",
"   </p>",
"   <p>",
"    Screening for and prevention of endometrial cancer in women with Lynch syndrome is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=see_link\">",
"     \"Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8895748\">",
"    <span class=\"h2\">",
"     Other genetic syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cowden syndrome is rare autosomal dominant syndrome that derives from a mutation in the PTEN tumor suppressor gene. Women with Cowden syndrome have lifetime risk of endometrial cancer of 13 to 28 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. There are no established guidelines for endometrial screening or prevention for Cowden syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?37/6/37992/abstract/27\">",
"     27",
"    </a>",
"    ]. Potential strategies include endometrial sampling and risk-reducing hysterectomy, similar to Lynch syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=see_link\">",
"     \"Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=see_link&amp;anchor=H8894433#H8894433\">",
"     \"Endometrial carcinoma: Epidemiology and risk factors\", section on 'Other genetic syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/12/23747?source=see_link\">",
"       \"Patient information: Uterine cancer (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/55/19314?source=see_link\">",
"       \"Patient information: Endometrial cancer diagnosis and staging (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/12/8388?source=see_link\">",
"       \"Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1267679\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endometrial carcinoma typically presents with abnormal uterine bleeding and is most common in women who are postmenopausal and with increasing age in premenopausal women. Occasionally, women with no abnormal uterine bleeding present with abnormal findings on cervical cytology. (See",
"      <a class=\"local\" href=\"#H336595\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endometrial evaluation should be performed for all women with postmenopausal uterine bleeding (including spotting or staining) and for premenopausal women with abnormal uterine bleeding who are age 35 or older",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      have risk factors for endometrial carcinoma (",
"      <a class=\"graphic graphic_table graphicRef62089 \" href=\"mobipreview.htm?38/30/39403\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H281205\">",
"       'Abnormal uterine bleeding'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Endometrial sampling is the gold standard for evaluation for endometrial neoplasia. For postmenopausal women, transvaginal ultrasound evaluation of endometrial thickness may be used as an initial study to evaluate for endometrial neoplasia in selected women. For these women, it is reasonable to defer endometrial sampling if the endometrial thickness is &lt;4 mm. However, if postmenopausal bleeding persists, endometrial sampling should be performed. Sonography is",
"      <strong>",
"       not",
"      </strong>",
"      a valid alternative to endometrial sampling in premenopausal women. (See",
"      <a class=\"local\" href=\"#H281548\">",
"       'Pelvic sonography'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=see_link\">",
"       \"Evaluation of the endometrium for malignant or premalignant disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Endometrial carcinoma is a histologic diagnosis made based upon the results of evaluation of an endometrial biopsy, curettage sample, or hysterectomy specimen. &nbsp;(See",
"      <a class=\"local\" href=\"#H1268005\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest",
"      <strong>",
"       not",
"      </strong>",
"      performing routine screening for endometrial carcinoma for most women (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). The exception to this are women with Lynch syndrome (hereditary nonpolyposis colorectal cancer), who have a lifetime risk of endometrial cancer of 27 to 71 percent, compared with 3 percent in the general population (",
"      <a class=\"graphic graphic_table graphicRef52285 \" href=\"mobipreview.htm?19/25/19869\">",
"       table 3",
"      </a>",
"      ). Strategies for screening and prevention of endometrial cancer in these women include endometrial sampling and risk-reducing hysterectomy. (See",
"      <a class=\"local\" href=\"#H1268046\">",
"       'Women at average or increased risk'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=see_link\">",
"       \"Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/1\">",
"      Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/2\">",
"      Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61:212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/3\">",
"      American College of Obstetricians and Gynecologists. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol 2005; 106:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/4\">",
"      Kimura T, Kamiura S, Yamamoto T, et al. Abnormal uterine bleeding and prognosis of endometrial cancer. Int J Gynaecol Obstet 2004; 85:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/5\">",
"      Seebacher V, Schmid M, Polterauer S, et al. The presence of postmenopausal bleeding as prognostic parameter in patients with endometrial cancer: a retrospective multi-center study. BMC Cancer 2009; 9:460.",
"     </a>",
"    </li>",
"    <li>",
"     file://seer.cancer.gov/statfacts/html/corp.html (Accessed on December 20, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/7\">",
"      Espindola D, Kennedy KA, Fischer EG. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia. Obstet Gynecol Clin North Am 2007; 34:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/8\">",
"      Montgomery BE, Daum GS, Dunton CJ. Endometrial hyperplasia: a review. Obstet Gynecol Surv 2004; 59:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/9\">",
"      Ronghe R, Gaudoin M. Women with recurrent postmenopausal bleeding should be re-investigated but are not more likely to have endometrial cancer. Menopause Int 2010; 16:9.",
"     </a>",
"    </li>",
"    <li>",
"     file://seer.cancer.gov/statfacts/html/corp.html (Accessed on August 13, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/11\">",
"      Reed SD, Newton KM, Clinton WL, et al. Incidence of endometrial hyperplasia. Am J Obstet Gynecol 2009; 200:678.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/12\">",
"      ACOG practice bulletin no. 128: Diagnosis of abnormal uterine bleeding in reproductive-aged women. Obstet Gynecol 2012; 120:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/13\">",
"      Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis 2007; 11:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/14\">",
"      Vernooij F, Heintz P, Witteveen E, van der Graaf Y. The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review. Gynecol Oncol 2007; 105:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/15\">",
"      Torres ML, Weaver AL, Kumar S, et al. Risk factors for developing endometrial cancer after benign endometrial sampling. Obstet Gynecol 2012; 120:998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/16\">",
"      Twu NF, Chen SS. Five-year follow-up of patients with recurrent postmenopausal bleeding. Zhonghua Yi Xue Za Zhi (Taipei) 2000; 63:628.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/17\">",
"      Larson DM, Johnson KK, Broste SK, et al. Comparison of D&amp;C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet Gynecol 1995; 86:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/18\">",
"      Frumovitz M, Singh DK, Meyer L, et al. Predictors of final histology in patients with endometrial cancer. Gynecol Oncol 2004; 95:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/19\">",
"      Guidos BJ, Selvaggi SM. Detection of endometrial adenocarcinoma with the ThinPrep Pap test. Diagn Cytopathol 2000; 23:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/20\">",
"      Schorge JO, Hossein Saboorian M, Hynan L, Ashfaq R. ThinPrep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study. Cancer 2002; 96:338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/21\">",
"      Gu M, Shi W, Barakat RR, et al. Pap smears in women with endometrial carcinoma. Acta Cytol 2001; 45:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/22\">",
"      Dash RC, Doud LG. Correlation of pap smear abnormalities in endometrial adenocarcinomas (Abstract). Acta Cytol 2001; 45:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/23\">",
"      Heald B, Mester J, Rybicki L, et al. Frequent gastrointestinal polyps and colorectal adenocarcinomas in a prospective series of PTEN mutation carriers. Gastroenterology 2010; 139:1927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/24\">",
"      Riegert-Johnson DL, Gleeson FC, Roberts M, et al. Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract 2010; 8:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/25\">",
"      Pilarski R, Stephens JA, Noss R, et al. Predicting PTEN mutations: an evaluation of Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome clinical features. J Med Genet 2011; 48:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?37/6/37992/abstract/26\">",
"      Tan MH, Mester JL, Ngeow J, et al. Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 2012; 18:400.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf (Accessed on January 18, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16924 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-5088ACF45B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37992=[""].join("\n");
var outline_f37_6_37992=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H1267679\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1267574\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H336595\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281205\">",
"      Abnormal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281213\">",
"      Cervical cytology findings",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1601978\">",
"      Incidental finding at hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H281523\">",
"      EVALUATION OF WOMEN WITH SUSPECTED ENDOMETRIAL NEOPLASIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281532\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281540\">",
"      Laboratory evaluation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281548\">",
"      Pelvic sonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1054261619\">",
"      Endometrial sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1268005\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14509188\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H282567\">",
"      FURTHER EVALUATION AFTER ENDOMETRIAL SAMPLING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282576\">",
"      Negative endometrial sampling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282585\">",
"      - Office endometrial biopsy with insufficient endometrial cells",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H282593\">",
"      - Persistent or recurrent bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282601\">",
"      Positive endometrial sampling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H383882\">",
"      - Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H383853\">",
"      - Postmenopausal women not on hormone therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H1241219\">",
"      - Women with risk factors for Lynch syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1268037\">",
"      ENDOMETRIAL CANCER SCREENING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1268046\">",
"      Women at average or increased risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H282996\">",
"      Women with Lynch syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8895748\">",
"      Other genetic syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1267679\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/16924\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/16924|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?38/30/39403\" title=\"table 1\">",
"      Risk factors endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/4/24653\" title=\"table 2\">",
"      Ovarian tumor markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/25/19869\" title=\"table 3\">",
"      Cancer risk Lynch genotypes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/41/8855?source=related_link\">",
"      Approach to adjuvant treatment of endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/25/9624?source=related_link\">",
"      Cervical cytology: Evaluation of atypical and malignant glandular cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/15/40185?source=related_link\">",
"      Cervical cytology: Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/58/26535?source=related_link\">",
"      Classification and diagnosis of endometrial hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/59/19386?source=related_link\">",
"      Clinical features and diagnosis of Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/41/35480?source=related_link\">",
"      Dilation and curettage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/51/18233?source=related_link\">",
"      Endometrial and ovarian cancer screening and prevention in women with Lynch syndrome (hereditary nonpolyposis colorectal cancer)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/27/18874?source=related_link\">",
"      Endometrial carcinoma: Epidemiology and risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36983?source=related_link\">",
"      Endometrial carcinoma: Histopathology and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/23/18810?source=related_link\">",
"      Endometrial carcinoma: Pretreatment evaluation, staging and surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/10/7336?source=related_link\">",
"      Endometrial polyps",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/8/131?source=related_link\">",
"      Endometrial sampling procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/53/38744?source=related_link\">",
"      Evaluation of the endometrium for malignant or premalignant disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/46/34537?source=related_link\">",
"      Evidence-based approach to prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/53/32601?source=related_link\">",
"      Hysteroscopic myomectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/3/37943?source=related_link\">",
"      Management of endometrial hyperplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/2/11305?source=related_link\">",
"      Managing an episode of severe or prolonged uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/38/41576?source=related_link\">",
"      Managing the side effects of tamoxifen",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/37/5721?source=related_link\">",
"      Ovarian germ cell neoplasms: Pathology, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/18/35113?source=related_link\">",
"      Overview of causes of genital tract bleeding in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/7/21624?source=related_link\">",
"      Overview of endometrial carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?18/55/19314?source=related_link\">",
"      Patient information: Endometrial cancer diagnosis and staging (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/12/8388?source=related_link\">",
"      Patient information: Endometrial cancer treatment after surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/12/23747?source=related_link\">",
"      Patient information: Uterine cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/41/2711?source=related_link\">",
"      Postmenopausal uterine bleeding",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/36/8778?source=related_link\">",
"      Sex cord-stromal tumors of the ovary: Granulosa-stromal cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/24/23944?source=related_link\">",
"      Terminology and evaluation of abnormal uterine bleeding in premenopausal women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f37_6_37993="Malaria eastern hemisphere";
var content_f37_6_37993=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F67536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F67536&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 693px\">",
"   <div class=\"ttl\">",
"    Malaria eastern hemisphere",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 673px; height: 452px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this map, countries with areas endemic for malaria are shaded completely even if transmission occurs only in a small part of the country. For more specific within-country malaria transmission information, please see the Yellow Fever and Malaria Information, by Country section in Chapter 3 (",
"    <a href=\"file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/yellow-fever-and-malaria-information-by-country.htm\" target=\"_blank\">",
"     file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/yellow-fever-and-malaria-information-by-country.htm",
"    </a>",
"    ) and the CDC Malaria Map Application (www.cdc.gov/malaria/map).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Arguin PM, Mali S. Infectious diseases related to travel. Yellow Book 2012. Centers for Disease Control and Prevention. Available at:",
"     <a href=\"file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/malaria.htm#2529\" target=\"_blank\">",
"      file://wwwnc.cdc.gov/travel/yellowbook/2012/chapter-3-infectious-diseases-related-to-travel/malaria.htm#2529",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37993=[""].join("\n");
var outline_f37_6_37993=null;
var title_f37_6_37994="Resisted thumb adduction";
var content_f37_6_37994=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65820%7EEM%2F75553%7EEM%2F54507%7EEM%2F68303%7EEM%2F76098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65820%7EEM%2F75553%7EEM%2F54507%7EEM%2F68303%7EEM%2F76098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Resisted thumb adduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 273px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAERAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDVsLYjDN1OCPetdGQfKxGfz/KsuOcMEUAA9gO1Xht2gkDd0ry1sfUtlhpF24QbQ3O4cYFVb2+W0snnb/Vx9eeT7Cp1TzQQchfUiud8VXAN7pdguNrzb5PoozT5rocdXY6rQkkvVSa5XDN0X+6K17+GEuiKgDbTkrwCKz9ElTfGzttXu3TAx1qRLo3Mk9wFYRN8sYPUL2/PrXNWl3M1o9DkNfiS3ullGMZx06VHcTeXGqk/N0x6Vd1yAmKX5SysMH2rDs5jPCiSZ8yE7H3dSOzVpC1mzaSvqy3GBu+Y4XG6s2CIGVgFyAx59K05InWKZv8Aln6t/Sq9vH/rHHDHpxVrYnfUsW1nAY3heNWZsHdVLUtPWOFpLdirL0H9KLjUEtmDMSBjGRUM0tzfRbTmGNuPViP6VbslqLlaKyXLzR+XCzyP90leAD9an0/R0mkR73M+w5APQVasbWK1tgiYRRn3P41cJ8mP7zbT0NZKpvqaKN9yQssKAxoFBOCo7CrUW26CIn3GOT9KbYqk6bXADEYzUtnapFJNgkbvlAHYetaKSuhtW9TShhSVvLjAESnGfX3p1xb+a3zD5RwBjrVy2QRWowAAoqlr+qrp8UcECCS7kQFEPYH+JvQfzrRvS7ZhJ6lCaEBxGgyB61m3XUBNpJ9+1R4uJmLSyvIzckLwKleAqc9AP0rknLW6LaMTUVIRkcfKeRivFPEenTp4guTEMwu27rjGa92ukGMOOD61554wt5LS5VlTO/jj1r0MqjTqVuSs7Kx5GaqpGjzU1d3PPL3TZoDvCjkDoc4rY8O6TPcTpkvHDwXZep9hW1pei3uqyqGjJXPCjoPf616r4X8GLbbGuyG77AOK1xtShSm+TY4cJGpOCdRaj/DME72SWWn24trZBkEclj3JPc1qpYy20gUuWLdSehNdRZwJbqscahFHHApmqWwK+YBz1Jr53FNVotHowjynOP5qWz+YCSh7dxmuc1Hy9J1Lc65t7lg0TAcK56j8q72NY5YskZUjDfTvWTfaPFqFtNp7od0R3Rse3uKjCVlKPvdNGVOFtUW/Dkf2aOQFsIz7l9SMVusY8ZAYn0qjZ28jp8vVCAeOnFXGhxkEgg+9EG+X3WTZXI2lTGNoPtSGYdlFDRgHk57cUxkB7803e+gxGlz0wKhEzA5P4CpWQLwMkmk2pjjrj60tR3GCY4JJA6GgTMD6mpPl4CgH1wKQL8wwvt0osGrGCZvXJpvmnH3utWCO2APemhW68Y9qWrHYrnJyOT6VEWweevfirZQkDLU4KemQCe+P1pWZKKeGc/dbHXpQVc9uPerrJwMk+nHemGIBs8k07W0Yyr5bEDtgcc03y2+UgjNWyFDAYJ4pm3PsBRoG5VMXIyeh7UNGCcZIz2FW9q4POAOaQqoxnA9/eq92weSKZQKCBn15puxckc57VdwpUAnk/rTW2gcccdetTeIymFGCuOKUY/ufUYzUw6EjB5yaTGM5Iz7UkvIaTte5B5fIJAwf8803YwU5x+FTnngY4puRwcnp6UPVbCsRKv0I6U11YA85PXrTyy5Kg9e1Kx4HGT6Yqmn2F0tczrFOjDG76dK1IA5Q5XP+etc9ol+pTaMHeM//AFq2Uu2lnES4BAyB616kTvUtC2WaFGdiMgZ61zl5ZfbbtNRbewiBWFF4DMe5/DtWh4jklt7GPYcySusfPbJ//XUuqTLaxRWsPBOFXHWlOXKrIad9S+jCaJbW3O5MjzHH8WP4R6D19a2F/cxKuQMjgVmaPbrb2ygDAHStHa28A8VxTk5yCMOXQydR4RyBknt61xsqGPU8w4Uyjaw75HNd1qNnJKMBwB16d65m/wBAuze21zHMGWJwzKRjcB6VvT03NLFiWJ5VitlZc4DvnnHtSTaaSmwyHPU47e1WLMrG7yPgzL/D0x71V1DUlt4m3EFmGce9bKPUEneyMS9jghugBhtg6npmpre5hQEFst1I6k1n/Y7i9kLMTGCc9OSP6V02mWlhpkYCohmP3mPzMT9aylJGnLrqR2kbTghEwcZwRitm30bzFDSH0JqWznhDbVAz1OPWtBZCDwOvFEYOW4Sb6aFeSwhWPKKFwMe5qK2tMSAvzz0rUZhuGR19ackY2btuQOc+ldMIJO5EnZGf4hvf7P0qSYjLcKif3mPQVzOkRPcGSe6bfNKdzP6/T2pfEs8l9qsFm3CQEuxz/EemfoP51p6XFGnIGQOOTSm7szcfdHw6ePM+UkAd6urYKCMEEkHigtg8v16AdT7VPb2w3B7jO4/diB5Y1jLyCzfUxbzTGuXKwgiQnCjHFVp/A0l4yvPKjIDllZTzjtXcWaSwvvUKD6EcAelb1vJHeIY3UKw5x/hWUVO907GVSSS1V0eeQadHpoCJbiFR3xwfxrQgG3B5Ga6LUbD5tkwyCOvauduoTp7bvvWxOD3KH1+lZyhJavUxdGL96Bcj5FWXTzIWUVBEeg79eKswn5h7/rWFzFq5jxxmOdk7dR7Gm3QeJoposkodrZ7r61d1KIrIHGc9Rio0wWRmAZG4Yeorib9jXv0kafFES14ec5wGYHj1q2+0dF/E1XC/fPRdwqYsAM7zXVhLypt+bIloxjkHtTe44/CmSvk+3pUZkAP8VbcrYrkjgEfKMVHgjPHNKJAVHzH1prSJ1GTxn6VLhd7lXA7s9gKBnuRz70gcH9eO9Jv7AYApKmu4n5EmTu6g+2M0gI55z+FMaTK5IH1pFkySQAAapwW4EmQBz0HPSkDcf4VEXOfvDPUClaTOPmUUKKSAeG5BCk/0pAxY4xj1quZAc4fOT27ULIxBALEfTpT5F0FzMkfJOOBz1zSFjkfN0qJmZjwrE03a/J2n6Zximo6DehOcluo4ppYdCeOvIqMLLj5kxn1prxy4HANK1hXHcZ+9n0BprFduTx2oMT4xkf1/OmtCwGPM6e1MewbgMkAn0pgddvPGOKcYRn5mIYn86R4Bg5LHv9KG0FroYz8dO/QUxpSucYqTykA5B47k1H5af3eR+lTzeY0mJ5gBGQMdhUbz4J55xU4RDkbVANIRjnaM0m0Fm9TgvhRp9zq9t5mpySxxRHY204aQ4zj2HvXsn9k6VFbA21qY3xgsWLE/ia43wIggtnBycMT7da9A8xZLc464/KvSg3V1Z1Rhywjc878Z2kyPYyx8xLcIWz2561WZjNrweRcKo+XNb3iy5xb20DIHk8wMGPtznHeuS8+YatL9obEzncSePwrKoteRGl9rHa2L5AbG3H3R7Vq+SrKrZ5YZNc/ptwXtgSCGAOVPX2rYtZmUjJzkc1cYJClImMIKnj6+1N8spgYzz3rTC71wOfU01oge3Hehpgp33Ofv7JZWGQNwGQVHNcxqemSJM9wV3oOAMdK7uaFi2McDvWbqECuvy59OKzemxrFpu5zVnZfdeY8HnA9K14baBoCotsjoSR1qM2jQyK0SF0UYIJ4+ores5opbdWwG2jkCsU5Gjk1qYNzp8cQWSzjeNgPuk8EU611NI5FiulMTDoW6H6Vu3PksV28Keg96y7+BJAQyiWMjoRW8JtEpqS1Lq3kMhIBU56c9aLq6KwqqsEX+Ijnn/wDVXGX9hcLmTSrryX6+VMNy/h3Fc7Lr+saOHOrWatZYJaa3csFU9dynkV1p860Mp2S3NUMZry5lTIVpCQSc5Ga2rW8JlS2t133Dj5VB/U+1c1oSXGpzvbacNwc7jIPuRqe5P9K9P0DQYbBBHFlpjzLM3LP/APW9qwb6dTRuNlcSztI9PtmuLjMkpIUtjLMx6KtaFpbbZDK/329Ow9KrvIs9+XI/dQ5SJfT1b6npV+JgQCOp9KrlvZIxnNl1EG0A8j+dSCIqdw4YdMUlvyASPwq0cYz09K2jBI5XO2g+3kS7i8iY4lAyGrD1e32tIkqdRtZDyKuXBeJxJHwR3qC/uDNF56gEgYI9MU3FPcIXhK62ZzuiSHEts5O+2baPUqen+H4VtR8nkDOawIHA8TbMkmW3OeP7pB/qa6BPb8K8ivD2c2iaiSkx00IeI5FZMYKyNGwHHStqPnNUdQiwwlXn/CuDFUvaQa6oIOzIim20bqfmXH61E3mkcYB6datcC1XuGfA/KomX15rTL/dw6uTPWV0UHSbcQdopPKkIBJTv1qxIRngc/SmE++B64rr0FykTRSDH3QMUohcAZcfhUqgdRninAGi6HykIiJY5fH0707yASOXJ9c1N2BODSgd8g0X0DlSIBAp65FHkoAwA5PHJqYEgZxSgZX+79aHdaidiEQouMKPyoMSZyFGfUVIeQDnt2pNhPr05pWe42MCcAYA544pSuBx06gU7YeOCRmnGMkgc8dqEpDukQFecDoD0zTNue/APPtVnZgE45pohYjp17U+ViuluQMCS3XOO/pSAHOO9WDC+MY//AFUCB+OCKlwk0F10KpBAJIA+vWkYHPIq19n4wEP1JpGt2wN3H41SpthzLqU9pb/CmkAdck5q6Y8ZOF9zmonjXbliD9OaPZ3E5IpMhyfemlTt5BHrWgsSEEljn0xSCCL+JzjuAKThZ2Y+a5nc5wV69OaaeTwB9c1ZvJ7GxTdcS7SO3esW58Q2YbZBE7Oe7cD2rroZdXxC9yLMp4mnT0kyPwmzQySJNOJXbn5V2gew/wATXe2PzWTFwdqjk56+1eR+DpNX0i3jbW1jN5I7SMnUIpwFH16/nXoOn6ndXaAMfk5G0cZqo1FTVo6noU4zlSRg385vtbjiBGYV+vJNVPFlgyCK6jDEIPnYDsafpyn+07mRsbzIT9OeK6UqkvyOu9HGGHtXOk5z5jRvlZymj6g7xxxtgLnO7v7V1kTMpVic471w2uadP4cvvPBMmkysNrnrCx/hbtj0Nbmn6h5keN2Txiux3Rk+6O1srjIAbgY6GtKNo2HBrk7Wd1dfMPUdOoPvWra3RQcn/wDVVqzIZsyQ7lx1+lULi0CplhknP41LHeYCgEY7nP61PLMkiAhfofX3pSppjjKSZkrEu0jBB6H6ViGK4tNTk8o5tXGSmOc9M11DR/MRjg/pVK6UEA45xjPSud07bHTGZkSSuysVPzK2MdzUL3incoztUYYelOkVozKM4BOax7piZPMUjHQj0qoR7lOxcumViR/GOmBziub1Hz9Tvk0qwVZbiUFWJHyxp/Ezewpde1cWFmhAMtw7COOJeWZjwAK7PwB4dOm2Ly3Pz390wkuJD69kHsKupUVKOm5k0nuXvCfh600PSrXT9PTbFEMtIx+aRu7Mf6dhxW3KXjDKnHHXFW44trYAFQ3kXyM2MY965k21cXMr2JGtIFJRFHl4BB/CmeR5SkoMqOcd6baTIyCNzg/wknp7VehQhiGGDXfQtJW6nNUvTepDC+05yDmrDElQPx+lVLlPJmBGdjfzpDOOeTjFdFrbkPXVDrt/3fWs61yTNvYCPO4+mO/59KLmZpXEaf6w5wM+nf2FVZblY4DGmQOpxUJ8z0WhvGm3EzoUX/hLUKBQI4JG+XoAxAxXRKOBiuf8MIbm41C/I+RmFvGSfvBeWP58fhXQdwfwrysW+ao12MKj1ZMmCM4zTZkyhDc56UisR2pS3GMGuVxbIT1K7RMLOFQcKGZsn1qGSMsDgjJ9atPEXB2yPGSOqmmrAQoDSO2O5renGEYKJN5XM3yJWbACEeuaf9kJPzDn+VaRiYcg5pDAxzg4J7etHujvLYora7SCDx6VIYAF3dAO9OkMUbgSzoCP7zUKYZHCJKjH0DA1pa2thX6NkRVcfeAz0yakMceASw496k+z8H8qQ25GOuKhTTHqMIhA6k0i+VnnIHY4qX7OeuRg9qPJJBJFPnQrELGLGACfemhwTwvPrVn7OCOTR5HPsfSlzpjtcriTA4TA+tNLtjIUenParYh9utAhGMilzhYplnU/dH5U7zJs5B7ccVbEIOOOeg96a3lRjMsiqo7scUc7ewWRULTEdfwpCJSPvtiq8viDSIT812jD/YBb8Ky73xnZQMFhhkl7A9K6aeFxNXSMGZOvShuza8h+vOaPJYcjpXOnxvGELfZNpBxndnFZt14/kDEQ2qqPU5NdUMmxtT7Jk8dQWrZ2gtsdutIbYHBAGBXnUnjXVWlHlPGO/wB3v6Vd/wCEv1E2g/dxGUt98D+lazyHFxtt94o5hRex20iJFGXkIVe+TXMa54jghbyLFt0neQc4+lcZquq6tfDy7iRipOeDgCqMbOUMZPzDqT0r1cFkEKbU6zu+xyVsyc1+7VvMv3V1K8jb2LkjdycnNIGkcKrDa3Q4qscsqKoJHB3HrVqKQMwwhUEcgete80opJI89czd2zqNThE2rKvpGuB+tdXpFtsgXKjJH6Vy1xJ5Wtxk7fmRefzrq7G8BTPG31r80ox5oxR9spPkRwd60lp4guYmJGH3fQdq6mwkWSIFX4I5NZPjy1dmh1O3U7U+Sf129j/SoNIvBiOQH5T6dK64Lk0CTuk0dn9niuoHiuFSSJ12skgyGHoR6V53qunTeFdQVB5kmjyHEMrHPlH/nmx/ke9d/YSgqGYjpxVu8trfUbOSC6RJIZBtZCOCK3iubRmLk4u6OTsZ/PVGDZ29MdDWkk7Iwy276dq5DULS68J34imZ5dMkOIZm52+iN7+h71uWt5HLghshgDn/God4uxpZdDoYrlWxswWx0qzb3LKBtOW9fT8K5xm43KST6Dpip4ptzABiJcZB9B60c1xcp0f2llAEag88j0NFz84bn+Hnisa3u3iwCSSOBnua0nulaEADLD7x96Ekwd4soXzJ5TBhjPH4Vx+p3UVoszysFjXJyeAK6DUbhdrMx6gsMVzXh7Sj4p1T7XcR7tHgf5QelxIPb+4vf1PFNuNNczK5nJ2LPgPw/Lqd9Fr2pxyIAv+hQyDGxD/y0I/vMOnoPrXq1syxIQBgL0zVaBRBNtc4V+Qfwq3IonUCPt+lcaftJOcimlt0LEK+YGckD0+tMuAoORk+opbQ/dRxhhxVqRATlRknqK1itNTncrSMCRPJnyy4G79KvQ3ZjiAb95EeQrcMv0NWpYkKsSgfPAz2NZl0JAPl4YE5NXrF3RpzKorMu3bRzIiltuehPasyeCXcymUKOgIHWq3my5O05GenYU6S42EhienJrsptyWo1RUWNmlWKEqm3B6t3P/wBaua1S4muLmKwsdpurptkZ9B3Y+wGTV3Vb5IombcNwGcVnfD+8iuPEl+J1Hnvb5gdj0QN84x78flV1J+zg2lqOpU5InaWVnHZWkNtBnyol2gnv6k/U81JgkevNLPc2sQzLcRID6uKpya3pkSEm8jIXrt5rx40qlTVRb+R5znFbsu7T+NKEJ6CsWbxdpcak75H9AqfrWdL46iAzDaEKP7zdfyrohl+KntAzeIpR3kdgq7QAR9aGCqMnAHfPSvOL/wAeXCoPntrYHn1aucuPFpvJiDeS3JbjbGDtz9a9Cjw/ipq8tDmnmNKKutT1a+1/TrIsJJw7j+CPnFcnq/jC7ug8WnhYIj1bPzH8e1cXDdtIcJA25u78LUjs6g4PJHIx1r1qGR0aD5p6s5KmOnUVloieScyktIxZvWkjkZH3wOySAghlqC2zLkE5YHqRViNsZAAHOCa9FxitEjBJr3mbOmeNr+yxHdqtwg7kfN+YrpLLxxp8wXzopomxyMZArzaXCTMc9eamiVfLwVyG4rirZThaurjZ+RpDF1oaXPUh4p0do2cXQwODkGl/4SjR9uftacdsGvLnHygA5Kn0olAIySB6Adq5HkNDo2bLMKr6I9Im8ZaUh2q0r+gEZwfxqq3je0JPlW0rY65OOa4RV24yOAPlpkSKcoCcH3q45Jhlo7sHjar02Oxk8cvnCWYyfVutVJ/G1+WAjt4ogTxnnArm9hKYXHHGKe4AXcw7YreOV4ZPSBEsXVfUu3PiLWJmbN6yxnoqcfhWTcXE05zLNKSOxY08ZZmUMAnf1ApsiqXzuyQPlB5FdtPDU6fwxRhKq57tjUQJy/eh8lcY6dDjigblBZzhz1B6VIMn7zDaOgxgGt1dEKxAIyB8w+UcnPvTPJUEgLk469atKditg5B6imSExnOQWHORTvN9SXyrYhWNcHCADsamSMKhVhjvmmMw2k/w9CKe33cABhjpnNS1fcpNJBH1O4cen+e1MkRVySMnvxTpCDIoz7ZqYABckfMBwKlxS1CDstSmyqckLgMMA5pBuVyNxOByfWnx4OHK8Z4zSZRhgKQM4+lN6FM3PF7SW32O7h+8WMRPv1Gf1ra8NXYvbeN5Cu3vGPX60mqWceoafNayEDf91j/Cw6H865zwpcva3kltOMMrFW9j7V+eYGa5LPofXwalC3VHo0kC3aS27IGhkUq6jsP8a80aGTRdWm02Y/c+aJieHU9D/nvXollNvjXc3zD071keN9IfV9OWe14v7QF48Dlx3X8a7XHmWgotp2exV0u8cMkTN8uM101pNgAHp2NecaLqKXMaSI2CBhvUH3rqrO83hYuc9sH8qhO2pclc6KeGG/t5ba7iSWCRSGVhkEfSvN9c0q78KymdXkn0NjgOxy9v6K/qvo34Gu8guH8zZwB60XXl3CNBOQyuCrRnowPat7qS94zScX7px+maxGZov3m4PwMn171q3RQgiM98nHf39q5TxH4an0J5LvSg9xp/LSQg5eD1K+q+3UVJo2sx3dqN0oz0O081jJcmh0KKeqOjiuNjBedwHrxVg3/lRHLZkbjA7e9YzyoYgQQGPQ9xWa7X+o3qadpSLJfTD+I/u4U7vJ7fqegojbqD1LsTHxVrzaRbCT7Lbx772aJtvlg8IgPqx/QGvU9PsIbKFILeJUhiRY1RRgLx29qpeEvDlt4c0lbS2LSszebNO4w88h6u38gOw4rauD5bxn+Bup9DXLKbqy02M2+hVuQNhVuh556inWbvHGS7DaO9Ssqzg4YK/QE1TdmBaFhtc8Y7GtoKxPNzKxoq4mYlQBKBnpUkd38m187+hHcVmQGRWLjOBxn3qV5TIS68SKMZ/vVpFdSJQL3nh2I7fzqKYeZnAycYx601AGUE8e9VJZHUkOQB7f1rRakqOuhWmVU3YB/wrPupERGJbA7k1fcnJLLx3rFvLSbUbj7NBmMN99h/Cvr9e1axfKbt6XOZu1k1KVyMrbocE/3/AKe1cnruonTrpZoVZ5EVlCqcdf516tqllb6XpcpCKkUceBXk9h/peqyu5+VATyPXpXbg1z14tq6TPPxtXmpSdzIOu6vKm42zFCerjoamivNekUMETcDk/Lx9K6nyU+8RvA6ECpBsD4CgbfyFfVOtFaRgj5dUbbtnKtFr0ykvLtOOh/nSpo2pXTA3l2yL02p3rqmGclQ3PAHrTgSpIYcEc8dPap+syS0SQ40ordmPa6JawjLjzf8AfOc+9aMFtDBuEMaqD2A6U9AyAHbkHPHenPKwbJIIJ6DtWcqk5PVlJRWiI2WQgKSAQfSmuhY5Azxx9aWRmbJZTn69qazdgMKevOKzlc0TIlIyQgKepNTRuSu3qQc0xtpxgZJPf2p6MGdWBOD3FDsJ305hs0W75mwR6Ac00b2ixt6dBnmrUq71ODnPftVZQ2/5iAKa1FoAjIAwOozz2owMDO7BGPXFObGSVYsT+ZpQqg4Lvg+op3KdkMG4qCTkZ5IqT5Q2GP5CkQAuoDHHsKTZl8Elecke1ITTe4oRAWZiecUm3dgE7gORTztCDdyx6E9qbt2jAOOcE57Gi7YKPKrJjHCs3y/Ug08gKTuwD6imKgwTjGeBmgjgs4O1euaTuGkdxpfAVmPA+9nvTxmTZjt3JqMxB8E5wDnA5FNBOCA3OeuO1NJistx8hYEsnJPamKm9gvQjtUgIA4bao6kdRQr4AA+hzT5gTvqyMjDksvy9Dil2qufLIAJ6UkgICnjGeoHNNQlDtPzA9qfS40n16g3yHJ4x0wKFkkw4YqG7GlwqnCoWf3p0YGAOvHQ0n5CWrIhHiMsOR2xTQCWHzAKT+VT7E2BRkA8gA1HsVVIYtnrjHSkiro4O31zUL/LETJGTgFnIxWtpGpTJcESkgjlSO31rM1mxdVfa2zJxxniuVvNH1TzQyXJJ/hbdggema8mthotOFkd1GtKlJVI9D6N0HVo7iBAsmGUc/WugtLlWUA4A6ZHevFPB2q3ht4kvVEd2vykg8P8A/Xr0XTdRZ9qlgG6Y9a8KUZUpOE9z6KPLWjzx2Mnxlph0XVP7Us1C2N0wWeMdI5D0b6N/OrGj3ryZCEZxkHuB7V08rQ31tLbXKLMsilWVuhB7f/X7V5rf29z4Y1VbaVi9pIQbWVm+8v8Acb/aFTNc3vIcHpys9Gt5MYKNkYxye9WmkBROPmbggetcxpt/EyrIgLK4xt9++a1ZJxEu8OHOc7hU7js0bNsFmcLcFvL6YHQ1yvijwfayyve2Tm2nznfEOD9R0ratLgykCMlpG7Dk/jWva6PPeYS4kZYc5KjqT9fSqdaMPiE291oeT6doHiPV9RWwsbuHysgz3LoSIF9cdz6L3r2rwp4bsfD2nC3s1Yux3zTycyzt/ec/yA4FatjpsFhbiK3iREHOFGBn19z71JKWEiFThMEfSuOc3Ve1kZufZizdwOp6E0scaSp5cg3J61Fc5U8cnufb1oilyzhRyOfrWsIWIbdtCCWP7O5hlz833T/eFKoWVGim4yMK3oaX7SHVRMMx/wBfam3fyjch3KBnI6ge4rdR7D5u5CwlssRSKwDdT2NSF48qQcjpTFvgYyJJDJ9KqusagGNyrE59Rj0qrIab6lv7QMjBGe9Mlfc3P51SCyr825D7ntVO8vZGdbG3YG5cbmY/8s1/vH+lPmsioxV/dL3myXFwLa2TzJT1weFHqT2ro9O0mKzhOTukfl3Ixk1S8P28VjEI15Lcs55Zm9T71uSTIyHaQacY3V2YV272Wx5z8SZoIIPJuI5JYyrMY1P3yAdq/i2K810q0e1jPmlXnkO98dN2Og+ld78TpR9pgUYL7ify4ri1fODuKjHPHWveyuly0/aM8bMKnvKmSs2CoHA70m4AlSpx6UB1kI4+VvepFIB4C4z1r0mzhkiMKBkbicHgmhV+dsk855zSyRqVZSVwVzg96IypVux9qCFZKwLGoA5wfQ96cVGApIwf51GAyKMsv1FSyOiK2DkHsOtD3HeyI3ByCQCMdaidhtIALHpUpIKZ6LURZTwFx2GTTswTsyF2OMA5x3qSHfsJCg45wKRcAgt0PUnimlwpYH14x1/Gge+ly4qnyhgZLepqERsZSowMjPPQU6E7VJJznjB/pRKNpUnAB4+lJK5PL1Bsb+SMDv1pfkLLg8Z5+tRLGQv7ttxBzjFKmfLY5Gc5/Cqa8xXW1iRGKgBAMjORikfdk8Z/GjcxZsjcDjGeKGICfLgAc5osFr6CYYjcu4gDBJ6UjEMmSTz2FKRsOFPB688e1Kw5LAYJGAOcUFNLYiLD5W/gHp608FS3zAjvwaegby23AZ6cDpUYwgDFVyeDiluPdajsbmI27UHfPWmOhJJDcd8dqcAHGGGHPJx2/CmtxJ8gAOOf/r0WJewzZg8cg8EdjSKrBhjGc4qRckhsYX0phGFyQSOtPlBa6DSydVJ9/UUzcQVIIOWqUgFcEYBoAUHZtGB1FNaIeqXLcYzHI3Lye+elJHznAI9x1p2NoJUcZwQTRGck8EDqfT86XQL6jlC5D7ScfqKaD+97ZY8Z6/jSmXAAGWzweKCA2SUwV55o1vqFmzGvoY5owr8v71zlzGUmK4IHcY4xXUvLwABx3qlqNmjguFJGM4rPEUVJcy3KhUafKzDjJUqy5BBzx2PrXZaTqXmKhcqGYckVxhV0BVxjk57CpEuTEU2HnOQO1eHisN7XbdHr4HF+wdpaxPVrXUEIxFKN6+p6U3WBa6tpz2moqJEJB3dGB7EHsRXAWmpz3dxFaWcE1zdv92GMZYn/AD3r0fRvB2qXMKy+IblbKD+GCBhJK/sW6D9a8ipL6u/3mh7fNSqLmgzz7R9SfTbybR72ZTKjb4XzzKvsK7zw9pd/rDBdrQWY4aVgRuPooPX69K62w0DTraRRZWFvG/QysgeU/wDAzzXV2lusKgDluma4JYnndqasJysrvcoaPocFiqrBHhscseSfqa2ViWNAcVMp2/lSPxyc+wpxp9Wc8qjk9SFmJDDtj9Krk4TBGTnH1q4D82MeuagnjynyZ6V0RhYV1sVmBRlcZIYFSPaqrN5UpAzhujDtV0yHyPnYbhwcDqazp5BLjCtjtW2xa1IxIDEqgfdJ3DPeqtzLz5o3Y6Eqf6VLuREO8A59aqtHC7Akyqe+CCKuNhJq4wzZT9387E8qRgik8xgcP8h9CKka3deIZFII5LLj8K4vxr4jbS1NrG+68ZeABwi+prRQcnZIHNRXNI0vE3iu20aHam2W6bOxM/qfQVB4P1IXNsZ7h91zI252Hr7e1eTSSPcTs85aSSTlmJyc1r+HtVl024CHPlDuTnH/ANauuWEtDTVnLQx8XUtLSLPeLe8LgMGAHSrq36pAcnDevSvPtP15GVSG4PbPSoNd8QB4fJgYsWHLD+lZU6E5yUIo9DEzpUqbm3oVPE+pDUdalcHCINic9h1P51loQjfMMZ4qJc+Wd5Cg8ZNPiOflznHvnFfT0qSpQUF0Pj6s5VKjm+o9wAU2Daw9fSnqz7RtAJzyexqPDbCeCPUdqduO1BjIPHH+eK0ItrckQbkbOM547H3xTt+1doPXIOcUmWKfMQMc0m07SWALDgj1pOw0NZUCYU578VLwYsuOQOOaiDFcZAAPv+lOkZQ69lz6ZNLcV9BCCR84GT0K0ydCNpIA9DnrUjnPze3+RTW+cqRlgeM9cfWhD0TK7D5Sx7cVHHjcWySw6/41O6HkY+gB/WoSpUMNxGe5GM07X0BSsyzGvyl5MKAMHmlMaOAAOQcDiq7MSwAbjPNSRyKJTGuSc8Y60egNdhySFBhhwODipDiQkBQCenpTZANxUAkH5qI2BJAAA6ZPrR5i1ZIpIG0cMOmT1pkRK87fvHn2pCOMoQw9+1O2Anrn1HrS0C2thqtubBPAPSl8wsoKndjp2pMIcocj3xSu2cKuUPYgcYpoevcazsxBVTjGSc0ELuHzZHb60FRsIOT2OKbuJCtnagIOT6U0mT8Nk2ShtwIIG719qjZfkO0fh3pXIwMdc9T1NMd8lWBG3FJRk9g0W4xU2rh8AE8gUoAXO3ge9BCk4LKA2SM07cuCFIJyOtXyy7A5pdRpG4AMQD600KMfKD7Z9KVMMjdCS2Ov9aNwUfKdw9v501CXYTkreY1n+XDYOKVW3LleRnJoADEYHUc5oMZUZVhjk0ezk1sRz8uojAFtq5LdvSkBwwAZgAeSDxmljIAbdlf4gAfXtSqnLHAAJGACMij2cuxftIszekXG0+uabu2NgAN6DtUasVJJYEEcZNbXh3wzqGsHzEjMNqTzNJ0P+6O9RWr0sNBzqysjSnTlVkowV2c3NYC6+4D5gPCqCck10nhj4XT3c0U2u3DwwH5ltYT+9f6t0Qfma9K0HwzZacQIYtxAy0rDLOf6D2Fbs5EEeV5lk4r43MM89vphlZd+p7mFy5UknVd32KGi6Ppui27R6bZ29smNrtGvzOfTd1P51eiU3Dl3ACjgDsBUVxxEqL91ePx71OW225CnoMfWvBd5u8mena2wkJHnFh16AmtOFtp561jWrFpNuO/5e1aqjCE/xYzW1KNhzWpe3YwSOvekZlJyP1qKNmljUhcY4pSdpOc5rvjDTU5mtQfLMSpA54z3qN2YEjBAx3HagOcnOeuQcVFO3AJbJ960SKSKjK2/G8cHqRVeaPauSyg5+8DirZXdk4+lVblSSAp4H9aLlXu7FCUu5IVixHccirVtabl3ScHtS20eJGLL35pb268qFsnaB3zVxBq2iMnxRqkOk2EknJYD5R0LHsK8G1KW4utQnubg755GLMf6D2rsvE+sDU9SOWzDGdoB71zd3EkkmScegr38JgHGnzy+JniYzFc0+RPRGWpXuTuPUVPaR7mOwng+lONk7A7SD3yau2luIlXc5J4wMV0UcPPmu0ck6qWiNKzUiME/LkY49KsK8ZkUqc8dxz+NVYd/ziOJgB1zxTkLBCwTb9Pzr0VTa0sczqJvcu5RXx94noPSoV3lt/PJ6dqZG8kr7htAPY96YGyMllwvUL2zRyT7A6kS5GuGfB6n+I8fWlDcgAYPcdqqh1YYkbjOAfWpyU3YMyCX0559qFRm+gOpBatlhGVm2sDzwSehNKIyS2Tt+g5JqJZE2lncb/vYzyP/AK9KrIwYo43HC88fN6Zp/V5ke2j82Pcg4AyzjoKYVCklicnkkdqfGU8xFbaT2IOMfUVOGiVcIVLbeRnI60/q8kx+2W1iuQD0Bye9KeY8AELjPFWbUmRnUhQPUtyRTFcKyh0OEBwEOdxzxT+rsbqx7Fd0kC5KnqOvWgwOyFmYAehrQlO2NiQ4kyOAQcDuTUaujRlUL5A5YgHntkURoW6kKrbQomyVBtkYBm457UxIxbFCsm92++w4Cj1q03zDhiG3ZwV45qsIHcYYgEoVYgZHBzxWsaMVqw9q27It+YQrK6oM8JVZXYDDJHtB5IPr2x3q1LkW5I37jgDIBzVaMq7885AySn6D0rRRi1doyXMne+g+Nt7KFjXIzht3HHakdpEKbVD5YbuflAPrU6oCvGABjOV5/E9qbNGpJPyc9sEYNJqHYer1I4zMAzJERjIBYZ4pqysY1LhyARx2FOZfLwFcc/KGyc/SmLGVBWNVXgZBPJwetFoh717oaWccM5G4YPHAGajjlZnJUgxbu69xU7QOFYsysOvXv9KWNWEauzDacEAnn8qOaKFbTUqtI+/awzgZJIzk/wBKUFGUYQdeTjn6VZlQ7iVb5s8j/E02ZSqgJ354oUrgl3IUUCUIAuSp3A9qkJQZKplOh44HFOywA+YgdTz/AJzTl+6AC3PQ+uKLlNKxW252FCFjGedvWnSBQQMKefugdBUkkj+ZzwB0weM0xM+c75K5698+tVcVtNBrD7jFUyRyD6mnSBIgd2ARxtqYhwQxI2/So5CxbI+bsQf50ldkv3dSB0QOH2/PnIwelDhBcFduA2MjPT1zUxUoGUhmOc9eKYZHyAUY++QB9KWrKVonTeCfBO5Y77WlG/G5YD0Hu3v7V6MkSRhURQqD0pqrsiIByO3tUgIMZwec/lX5TisTVxtT2lZ38uiPuKVKFGPLBD+Fx6egqo7eZdISQQOR7U66mCvGMZ4JJqvbsGmOCQB3rKEUuhaWlxLxwAGBy2cmkEu9NuevvVW5LIrIo2heeahtGDNtyNrjIOe1aKNtyrWL1lKolyrcDjFbUL7wMNj39a5WKXZLtVc8kEnqK3baY7QSF4xj3reEFHQc12NiIfLyfl9PWpWmA3bsbSecelUILjPIHfPNW3k6bR0/WulM5ZR1CRizg+g6VGysw+bp2FNVlY/dIIPXtUm4ENtB59qvcGrFdk+U4QGqjoxI8vg+4zmrpkzvBZQo7mmICA20g9we1LlHsVxBIsZIAHpXGeMJ5IbWTDgnp6Z9q7e6n2Jgda828avLd4jiXLcsRtznHOB7124RQlXhGWiujPESlCjKa3scEtqjoGZ4wR85XkcZ6fyqc2kIEq+ZGZAR83UYx39KYJ9sCq5kDfe2PHyDnpnuKaJVJf8AeiVyQudhyFPf3FfoHKuh8S276k0sSRRxDEbqP4SeTjrmo/JREaQ7uGALbgcHtSbiS20gkZwjL1x/jUckoWEAMAw5JI/XNJaOwNuTbLaxhojvZypz86kY980gLGNiiysyEAKT39R+dQhiSisEUEkAE81KjoIwyjCseSeDj19qNhPSSJl87cJJEkUhioB7+v8AOjiQbCz5AyMjk/4+lROxV9u9CgbIOc4b/PamuPnVjhk5wy/4UN9hxjbYmDMv7wq5IYgccjPHTvTow2Tg/O2AWK5GB0OKjRypMiJucEcO+Rk+noKfbOdis+SxBBOe2f5Um20Pl0LKk527mzu5BGBk+9S+WSdmS+BjAXIGO/8A9eos5JA+ZywJJPO4/wBKWA5gBKhpT8q7WxkVD5iopXHxhS6lgA7HOPb/ACKXYBI8KYT5eoHWlkZ1Eabdz4Dbk5AHOM1LGJTJFGyMqjcBuPHqeO9JtjsnsNUKVfACqpy2R1o2KLdTHtZMHA6Dr0H5U/LBA7IycZDbuGFPiK43HCIAcAruOT/Kk2w62RGWBjYkLsJyTu7f0pAINhBxt5IJbOT25pwYSW7hdq7gDgDsKSIx7GG8bVJYLszyfb2o5kFtdgjDSB1CMADy2cZ+hqNI90pSESZLEZB9umakCr5TopGSBknnI9aUopDAAlSeFUdB71Lki9ewciEKFIJUpye/fH+NVowFOARtU8gZwBj19athvu4AU42jeOB601WDMSyhEBzjjkj+lLnSQOD3EMiswUsC2OFU9TTZmaRBtjbBHBDdT2pJJwELGNS3bIBNL57OoXA2Z44oUl0QnC6IysvyMA3AHbjPeiPCEZLjsakSQBASMgcD/GldQEVu3Xmk5rYpKwhUExuGdcjgY6/4VGsStMzE5IPYccU5iAPQnnAPWml0B+YfvOwPf8KOdDULgUzhS5JxznoDSCLaoQTsCDgcdvYUufky6gsDjIPFMSRoTvVR15GM0KoCgBjyNglOB14GTU6H5wN4CqMbcdfxqq7s0oQqgDdcD8qerFRtYdsgnnNS5sOSzHyusgIKhiOmBUTZ5CgL25GMetSKrEOAQGAGR61EqKQQOgJyaXOHJoLuO0nG7ccsPXHSmpIIsZXLA8jpUkbZLKFww9vyxUKFgcYyD3NHM1uDguxKzANlEBY8ZIz+VISgQM3A6Akd6YW2xDbyeQMUwu5YIQQpGAKV2UoWZ7TuznBU8dqasjYB7DOc1U8wRnaWyAxGR29KWQhlQb+DycHqa/LYx6n2/QjvWBAO5gq87s0+26vg5VmXnvnFQXLfumEjc/pmn6fhkxlV+prXl1QPVDb8sUJ65IyPpVOxcZcjp2B6k1dvc7cBcLjHXn61SCFJDwMDkjOPyrRRbYntYLyQwvuVThjkkdverkF0uxQQwJ5qnORIybSAi/MaiZ/LdSCMHkkngCtbWGmmrM6OCckoVBHue31rR81gfmIJ9FNcxZXIDfMScep4rVN8Ase1Qqjrg4zVxV1oTKJosZQHIjIAGeo59qqtcMobd1A4yaqzXjYwhBOPX/Oaptc5yOTk/lVMSjfcvK+45J/XpVlJCowDnNYTSuWHzAKOvvT0uxjA5X6003uwlrsWtTuSsLFeuK5m0iS8tbxpeqTbs9xgVvu/nLgKcY71m2SiKa4gI+Z8t0xxVq1hbqxyni3w1cIouYQ7SEhiucB+OCPQ/wA65Eb4lw0bfMT1O30z9K9z0tEutPNndZcx/L83Xb25rkte8MRxvJ8g2EcMF617eDz2WFgqdZcyXXqePicpVebnTfKzzmYRiQ7mwpxklunocfWmyvGilGJU9wBkk55rZu/CiiTerMo6EAU7/hGUAI3ucjAyehr1P9Y8DZe8/uPO/sTFa6J/Mx1ljYFRuG7jPoB3qWWaN5Q43FU/hI6/41dfwzcxq3kOpLcHIycVQl0u7t8KEOAcg+prpo5rha/wTRhUy/EU/jj9w2aVSAPvA8en41MtzGHhUr8q8j1z/hVISlQ4lAUU9lAjyGJAAIPU12OpdWRy8tnZFqO4xJK2QDt67e1SpOTGQFwp5OR/IVnxzYwVyFPrzipQ7GRiCdo6Gp5ncvlXws0kcGLByVPBJHIPalJKljkNvAGD1qpEWUABsE+lSRSMNwHDDrms3N9GWoJE0cq+XGASDyMj2qxltx2gk9z3HrzVeNih9j0AqQMxZkO0R7c9fvVPOxWSdx6bidrjKnoM8GpGVSAqksR1x/Kq5LFCzcKh6Z6UofCgggE9sdam7bLa7lgIRjg+gx7U1QMtvUE+tCsFYbXPvjtTEAWVgXYknA+lK7Y7k8W0feGXGM57il+/8yZHtnkGmA4JdWJGNuRSGTnBPOPm9vahJ7ku7Y5ip5Ocnk5p3l4QMwGevFI20KAvfrSOJCmBG2RySOaU2o7uxUbvRK4yQdAozk5AbpTlJI27eByOaUwSeUsjq655z7U0DDBRzn1PSlGSktHcbUoboVN2ASARjOO9BdmjPyhQeafjaxOCxI45xmo9uZGZRww5Haqvfci2mgAoeece3Whm+YN8u4jGcc0piIRfmKg+p4ppBzjoecMeoFLmK5dxMngKuDjHIqJH3KV3cgkcL6VKA6uMsOmc/wD1qayBpeAzMx/A/wCFHN3Jt1Y2XdsByTtORSGU5yrMM/kDU7FSw24VVHYU0hdpC9+QcUKVyrpPQZl1wAd2epHWmDcXVQPlIPepAuAQM44+uaJdoTb2xnPoaLktdWNVXC7Mge570jyBSRj8qF/1ecgjuPb1p42n5jtOcjpyaYXa0I9nQg4HqaaI3AJ4CdVzThG5Q8KfY+lPwrxguBtxkfhS5g3PRcyF3KHOBtK45I/xpzSBISw4YjJzUxCYjZTtZgDn1+tUrnDsEmRl5zlT/KvzW1j7ncszOHjCh1ZWAPHr9aZafun/AHgIbPBqgd0CuFVQg+Ug9zTJJjsBDDLcjvWkY3dyZOyN2KUSMzNgc4PvUEwfcxKBhn65rGg1WMSIGkK9hnvir41K3cMI5RkcYJ/zmuiNOyMZdyCSZwGDDYe4/liqc9w5VIyQQTnqOMelXLy6t3QbyvA6E/54rnbm/gV8op3DtjOBWvICk7muJVBJLe3H+FTR3qLGjF8fWuUbVFeTKSHI6kjHFQi93KNhJXuT3qvZ9C/adGdZJqWHYg5HQEdMfWq9xrBVMYbvgisKOWacAL8wHJAH8hWpa2ElwdztgYwSBzTcUkDm2hft1yR8sL4B53nAp6Xl1vJKAJjs3StG20i3wSQzjHIbsfbJrRjsbZNjLAsa9FX1PrU6E8zZmWdzdpOGKFl/u7uMV0NnFBfgO7YkX04wfSq5t4o1bA5PYf096ibfA4ZT8vY96V10NL8y8y7L5sE4YjLoOCAcOPr61uWssF/ajIVg3BB6is/T50MG6XDO46n+VaJsI3UNbSeXJ3K8g/UU07+hjNpaHN6/o0kEbtbKXj9Mcr7fSudnkmRSHiKsvBr0VJprcf6TCWUfxKNwpt1p9nqKblK+Z2K8EVyVaK3iVGo42ueaLcyEABeSehFSZaTcHxz7V0l7ocsLMwVXA6lRzn6ViXB+zOFeF89sjrXNyuHxG/Op/CZV1pMUwJ3ImeBjr9KyL3QSgLW7AEjha6kiJzgxMB7jmoZ7VP4C6A9TXVhsdWw0uanLTt0OerhadaNpo8/a2ngYI0T7+cccVNBY3wUFbeUlq60qyShosuynjeuf/wBdadvrBXi807cg/ijbr+B/xr3f9ZKklblX4nnPJqV73Zxi6VqW8FIH2DuOtNOm30QxLA464+tep2F5pt8uIHUSd45Btb8v8KtTWELsAwAOM4xSWd4l/ZQ/7LobNs8he1nWMF43BHp/SraQzKsahH3ZzzXpN1o8JXJjAyOcVizWeGVF3b1GVPrTlnmIStyL8SYZPQltNnLRaTeS8/ZQEzk7j1q2NEvZMqY9o+8Oa7mzjTygzED68VcjntlGTJFyOrMK5ZZ5i76JI2WVYddWzz9NEuljK4Geucf1qGTS7lJlEibUbADgZ5r0hHsXAw8ZPb5xioZ7eBkfawOOnOaSzvGq97fcUsqwr01ONt9ClkUbgVJ56YFakPhmMrl0Zz35rqrGKPywSctjnNWWCHI447CuaePxtX4p29NDeng8NTekPvOaTQYlOEhVQPXmrdroyImQFB9MVrzSJt2kgAULIvl8sMDtXHOnVq6zk2dkZRgvdSRlTWSqpBVPesDU9HVyzxAKw5GK6a5miU8nJPvWTe3iovUAr3rag6uGfNTdgqU6eIjy1Fc454yj4ck4PX1pAWdC5BHpj+GrF84kuz5ZGT83A6Cqk3yDdglRy3NfcYSqsRRjU6s+OxVH6vVlT6DGDFirnkfxGmMCWEbcgfrVwNGXjbnbjo3NNmij+YnkgA5A4ro5Tmv0KUwYblIJ29hRlI2KkFgRzg4/CrBjLINu4ep7mmBWfGNufQU+W+479BgLHJYDBAADUkvvmrUkEkhIXqOhxU9tp7yRqHHzcHJ44riq4zDUfjmjrpYLEVn7sHYzsBlBA6c5ppDHIA3HPbtXRpoyE5fLHsB0q/DZxw4Ij+pYc15dbiChDSlFy/A9KjkFaov3slH8TjSGVwSvPcYpihmkL7cBfTHFdtNBG+Qyjp6dKzL3TIZAxiGMjrSo5/Tk7VItfiFfIasI3pyuc5ubh9uBjoTT4B8ucdPXoaS5tzbMFKk88c9qa4wMDOfTtXuxanFSg7o8SUXTfJLdHoT3aCFt+F54HY1Ab6N87Chx1BGKwLm6k8tioSUcFQjc0sTRShUeN+cnHI6elfnsaa3Z9ra61NKSbfwMgZ+ZCen0qJ4dwLRcADqM1BbxomFucq+4sCzYOPfHWp0yA21nBbJG07sVvHTYm2ujM6e3yytg4J4B4xVaSGWBw6PIrLyD/nrW9HF5iEzfO5GDximXMYX5FDeWBj5v8a0TtohaFGzJuFIuTufPXoB9anjsYt52H5R95geSfWo1g2nLbAg44O7PvUktwiw/u2AkHO7HT8KpyTMWtR8ui27RABAHHPrmhNMggLMtsrngbT1/L0p9nPcTIC7OeDklcE1qaY6yLIuCm04O7ufalzhy2vcq2lgvDCKNHPO3sPxrVhtQqr029MdqsxKVCoDmTqcVNhN4LMQTxyMZo5luJjUt1YE4BAH51KsOCDyF64IqW2DIoV+vTGf5VYIAJyDkfrUX6MLtFb7MCCpGQex7VXntFCFWByf5Vo7ugAIAHUdqUgbCCoDeuaTKUrGSYni52ggdOav2Ny8fDMc9QBUoXzM7wTx1NPWFeMZ44qVJjla2poRXiMqqccjr70yeytro7oxtfIJZTg/pWbICrgZyPanwzSpkj5VrTmi9GQqdtUyaW2u4GHl3DSL2Vhn9azryEzA/aIDkdHB6Vvw3e6MK7KD296lxHNlVAJqZUVLYaquO6OLWNbZgs6B1P8WO/vVhraCUbkXGe+K1NT05GO7diReQRUlvanyg23kjkVzPDOOx0e0TjcwHseCQFI916VDLZIIx8oJ966T7Gu45+U1XuYD90AZFCg0CnfY5WbTYWiAdF3Z7r0+lKlvdQLi0upFX+6W3D8jW+bViOoIz6daryWB3ZbI44xVR5lsW7S0ZiNd6rCT5typHqYgcU1IL+7uxvlJQrkNH8o5+laktnIAQpz9az1uruyuQtooLNyVIyCPUip55fbIUOX4UalnoEWQWy46Hec/lmtIaTAAMQrtz2UVWg1W6bBkshu7fvMAn8qsf2le4GLaADtl2NH7ruQ/aDzpNsQMxJxwAFxioptDhIJRcZ5OKedQvOcwQk+27pStqV6I/9RGM98mofsn1F+8RT+w3dohWCX5eytzVSK9vEZzIkWE4yM/nVqbVLxAS9vHtI7Zqgb3dJmWEDnkZOKn2qWzNIqX2kSxy3UkpLIoJGQd3Wle1uH5bjmrNtqNsm1JVYHpkYOPy6VfOo2CAZuYTxwM8mnzTltMq9uhzzaXMxKrLIBjuaoN4aZnBkuZ5ec7WwB9K6ibU7NMlZgx7BecmqMmr5b9xAzY6M/ANZOrOP2jRaq9jmr3wtO0xkgkVP9nHH145qtNo86Kocg5/zx7V073l9Nkp5cYOcYHb6moRDOzAzEEgdxzXoYfO8Vh4ckXdehyVsto15c81qYK6O2AfN2+w/lT5NOXKAyHIOeAc1tyRzIhCOMeu0Z/OmW0ShiCCW7c/pTlnmOl9q3oghlGFX2fxMX+y2yyoWO496lhsBD8uzHPXqfxroFgcn5UZMUxrVycYwBWFXHYvEK05ux10sJh6TvCKM+O1jbOeo9Kn+zqpO4LgipHtXRgyH3x3pzKykKwzmuZUbPc7CJLZSGKuwYehqJ5JIm+b5+x9auAdQvH07UpiXA3dOprRU30Mno7la3lFwheM5IOCDwQfepJYVDA4wSM8VVnT7Jci4izlR8wx95atl0J3BgQR+YrqhS5kQqtnZnOa7EjIHdThT696xFYIxAHOeTzWt4iuURGRWBB96ySdrKxyAe2etfU5I5ezlB7I+azuMPaRl1Zr21qbXckIKvt3Hcfve+auJMkmS5YSdto5J/rWjq1iwiJhjBkPKMzY2nHr6VRijeRd6xuJAPmwcZz7V8ome7zJjCpXJiJbHLAj5qsIxDB4iVlwCOMcepFDKqxqWEioTnjDVEsCk52zEk56YK59afMS2iW5eSN/u7Q3QkZU/SovtL42sN5JHH9atxxseAqkjBySQfpnpTZbWSSYGKNAW52qS31rRSM29CpPkYVASCOABVfyGyA0ZBPHTAU1fubWONdsjhX7Hv8A/rqnIZIJGReVAzuz+earViiupcinjD7eVIGc+v09a0LeYKgbcSenPpWJayMwQSMGVsN/+s1o+assfluAsgHHoKj1DyNyCYsF6MoHNW1w3LbWGOM9q5u0leFwrSBgf4c9K0luggyDnrnPQVS2uRJdjVDhTtVgBnPPOfapVkDZYHaBWUkyyEEtjPY1LBOIzhCATxyOKerFbQ0yrE5BDHH6UvU4b7vriq8UjBwccdwTx+FWPMUfKQASOPQ1LVxXsOAJbBIXnt+lSbweCSSPSmb1XI547dMU15lPy5U8YHPNPl0He4SY6IQd3GcfpUiAqQOAuO9Qu2XDFiMc8DrUiybsZX2yaVikyxGE6jv6irkR3HjBrNZ+noeARUiybcDcc/WmnZCauXZowwGck9/arkezyl4AX0HaqccxZQBjGOcVYVsrjHStlUVjNrQbLGshO3nHrVeS2YE8VeiK4BzjvUwAOaVk9Q53ExGt2GB2z0pJ49zYK5Na5QKRnnHNRtGCxPGfpSlDqjWNW7uYZhCliQcVBDZfvJHZQSTkE+lbc0APy8YPehIgCFAP41nyXNPa6GcLdc5VeMdak+zqFA2ge1aHlZJ4Bpvl85wOah0/IlVLlZLfhSV/A1MYlxhkGPpUrBgRjpj9aMsFwRUezSFdvUgNpGdwKj24qpPYROCAi4+laALZyKZjLE1LpLqVFta3OcvNHgdCwiAkA4IFVF0aG4iVlTLDHIPWupuP9WVx1qnpAzE6beVY5IqXSR0Rk+VyM8aVDGB8gJOOo6VMlipBAUcVplRu59fSmsmD1H1qVQQvadCqlpGzDAXHSia0RW9B7VaBCn5e1Mk+bOc4Pf3q1RFzO5nS2sZHOc+wqmIViu0UKCHG0dsGtPBBK8E0y4CI8fqWAzTVBGinZ2ZXkQqxIzz0NKIcKWYkHH6Vo3CKwLZGcfSqbAKOc9MfjWqojVYpiEA7mznPWoZ4Ark4J56CrkrpjBI3VE7+YvABHc01RKdTqVAgzkDgdKSRkK4wB6+9SzSgKRn8axdQvIo4maRwqAd+K2jSJ9onqx2pzxiFy2AcHiuPfxF5SiCMNuQYyT0p9zrkN7OI4z5sa5DbTyce9UI7a3idWQRxbsseDkntz6V7OX5ZKr701ZHiY/Mo0Wo09WTwztdxuj2zbN27zW4Yn/CpmUZAKk87fU5qLA88YcvgZ2f1qZhlF2YUntnkevFfQUcLGhHlifOV8TOtLmmdHD4uspkxJIoGB25/+tUDaxbxSndMuR8w28jn0/lXHPo0Cu0vQP02nO3/AOvUDaYWbZGGLYIXe2OPr618GoQZ9lqjtxrlszFmuCjZ/gAIIqG712286LbKrqAc7+tcC+mNG6hjKDjHByKsw6dAkbEq5IxkycZq1CCJuzrrnxJb7vl3ADkZGaojxZCmQyMYgefesi2SF4yIELMPlGeCDV2LToUULOA5PJ74P0pqMR3ZoTeLY3TdGG4OMum4DNEOv6cHZ5cITxtyTz6kdqq/YYvK2mP5CeR04qRrGzkjAWLA6FW6/XNNxg3ZCXM9DWhvbG7J2Tou7ABUjj29qmW0V5iISCg5BY/yrkJtKgTDRSNG2cfL06+tPjt9QgcG3un3AcDJH86Sir6MPU6szSxzBHjLdlcdatxXMzM0YiG4d2rj1vtVAAlQEDnPQ1fXVLpU2kMCfSh030GndaHXwuZIwSBnoSO9XLe6jib5uR1J9q4yLVL8QgxRBgP4hxil/tW6f5XjVnyD07UvZvUT1O1ivUJCowKk9cdPrVhJjgkuu36VxiapMjD5dhPHy1aGrujKXThuT9f6U+S2iFa51iSGTbl+R2Zun0q4u3dubIPc8fl61x9vry5O9AFzjIGTWtBr0PGTgHgNUO6E1Y6EBCSCCR79qVE3dEUj17VkLrEAYfvFBPcVZXU4pCNjKy9fpQCuXypxgybf9laUbV5x0GRmqovIcnnIPbNJ/aMG4KhG4Dvzipemg0zSgJXHJ5NWHbYpAPB64NVbe5jdAw2jPbPFStIpBOcZPeqViXLUtRSoEByMjvUn2leAG596y2I29due9QNLg4Unjue1K7TBR5jaaYN3wPUU0zgfMT0rG+1FEPPGar3F6xOM5z0xQpN6MpQNiS6G7g/SlS43jcSa5sXJLAFsMewqzHOw4LEHsAelF2inBLY3RdELgHI75pwmUjPNYBuQHGGHNWIp8t97Bppt7BypGx5wHU5oMwIJ9qofaAwGQM+1OdyrA5B7/Spb6CLiN6nIqXcuOSorNaYKvLYOOnaqsl0/mBUBZjxiheYb7GrIQyk5GBVaPEUjBT+7wOh71VneVV547nFVRNtHXPrVJGkdjVeReP1pqyK689O3tWQ1583JwKVroYxu7djS5b9C+U0vMQAnvUbzhlOePQ1kS3w28HjOOuKpXGqLF951C/WqUbjukbL3HBC45NUp7kYJ7j3rmLvxPAmR5m7rnHSsy48UxblzKik++K0UGgVSO6O+/tAOpDHgdPeqr34ySDx0rz+fxTYwhhcX8MRxk7pQKw9Q8dRysYdLMl1L32ghB7lv8K1p4apVdoRbMqlelTu5Ox6hNfx87iMD3xmsnVfF2n6UhF5dRxk9BuwT9B3ryK71TWL5szXzWqMT+6gTn/vo8/kKowaZHDceeoLXB6yyku2fYmvZoZJUetTQ8ivndLalqd3qXj68v4/+JHpskkBOBc3R8tPwHU1zr22p6rKJta1BpgR8tvCdkaj1wOT+NVYbdvOUl3Djtmp1cxnIZvMXIZsnoT617VDLqNFaRu/M8atmFeto5WXkdRYRxQQCK3WNAigkKNoQHufWnJIGSQK7MwxukeMqc+gGOa5syTclZWx/FknB9DSEys4MkzsTxnJ4NdijZaHGk/kdI13bwHbJIN2RufHf6VJDfRLllu4VJOCWXNc0sABYuzHacDIqZYFbhOT1JP8AKpabWpTdmrl1b8k5MR6YYDscVZa5SSJU5fglSGHI964B/FkbMGEsasMfxcfrR/bU78wYXuMH+VfA/V59j7JYmHTU9Lj3rt8uLfnngdPx608RGUsJFUNjO48gfhXAQeKb6BQEkJQ9V9farieKrpjkQqB356iodGUWUq8Gdd5EcO5gi78ZJUc59KgW4ZnUskgbkFT/AFrCTxM82VICtjrgZA9hSrdz3K8z8YwACBik4vqae0TWh1HmohysigMMZPY0FxIAHTBHfPWueFvE7h7q/SM+hbnJqAz2SyeW+ouwU7W2Of8AIp8nUmU7bnRtLt3iKVfRwT/KoU1OKPCOWfB4+asUzaQSPLuWx6kkU6F9OIDLcx8nht3Bq1BdSW+ptPrKOhRVDHB7UxdSuFUkqGx03Hk1QAsV3MbhBnowYYFL51kAc3MbFe4P6g1XKlpYm9nqzRXXH8zMibkz1AxUy66nAZlGDwGHT2rPV7Ux4FynThgQc1GfKU4WUHf6ijlXQad3Y1hq8TOzHaBjp3z61GdYhXmRWI9hVaz08XeSkqqRyRVx9GSPaDKAT1BHNDUUPUS41SF4wqbsA7sgcmoBq42HAJwem3+daVpo1sJB5shAx0B71qR6DYMq/vCR061LnBbodnc5iPWFLHcsiqeMgVdtdY+bIkcp6EdPqK6CHw7YFP3ozjpzVO58P28UheIFWOQRu6Vm5wZcUyza6wCwHHX6nFa631tKQzMDgcjGCK5OGyeBQC69cNjqB65rSs7fYrIZGyOQN2c1HLE05erNZrwwktBOu0ckMccVJHr0sRPn4CngNnINYzql0AAw29Bn17gmlWyiB2qx2Pzsbnb60mrCcNDoF8RQMyr5qNn3qc61bsCC4weue1c+dPt1DbYwyYyQuMj3qjc2ERhEkUwx/EEG01SSkZ8rWx082u28Wdsi4Xg45rMufEELqTF8zfWuS1H+zrCDzbq//dHvI+MH0rjdR8W6ckuzTEvb1U4DwRkAH0ya3pYWVV+4mzOpWhSV5Ox6omrtCNxy20ZDZ6UNrcUjpulIGckg8/h614y/jPU7cr/xKb5onBIDRn5l7nPerMfjWC4jYLpepGXGCFgz/WtZZfVTtysyWNpt35ke5wa9aE480bPU8YqZdXi8zdG6bRwRnmvnv/hK5FLu2mamhXo3l9vcZqW38aQsgZre8abPAEeSDj0zSll9XdRY/rlH+Y+ho9ahcb43wfQ+vp6USa0qOPmUE8gZ4A9TXz9J42mtH3my1DyWIwCnc98Z4NTjx3b3Kn7LBf3DqMmNIST9KX1Crs4jWMovXmPc116PG4EkZx16mrCapawHdNcK057A9Pp/jXzrceOlFr5ktnqEBbhCI8KBnnnNXbbxbocu2T+0XiUL82dwbP4jn8KzqYScGuZGkcTSktGe9zeIIA2xmXPuc4qFdbt5QREwLDg148fEPh9Y8nXIiOv38mqbeK7Z5SujtcXhJ+eSOMqmfUs2OKdPCzqStBNhUr0acW5Nfeeq6tr0Vq4YnMY5bvj3rDv/AB1YwxtmRQuOu7gCvPZb3UJ+LrahfOBGxk4924FQLZKqhfJQyY428knPoa9bD5DVlrU0PNr5zSjpT1OnvviE9xGV0i2kuuOGyI1/76NYF3qniK/c7pbO0jYZPWRh9M8VMgKLgDdg/PGBz+QHH1qZFDRs4ZVkUkng9Pc+le5RyjDU/iVzyK+a15O6dkYkmkG5kD32oX1wcgYMvlj8gKgfw5pQK7bTeS38Uz5Psea3EDKXXfh8ZA354PvjpTlVnZxG/wC9AJOcnH1x2rtWFow2gjilXqyd3MxrfRtMh3bLO3U/7amQj67uMVpQQqlsNvRemRgL/iPaplgBO1mDB+SQCcH296Q2mwhSNuBkZUAt+PUVsoRXwqxk5OT11EO3ad6goVwu3jB/rTVjB2xxkkIQCxIJP9KvrCixFgC7Ou8KWABx7nvT2kgYqsgMgAyQABgn8Ov4UJXBSSRVaJ2l2fu8oOSjbs/41IYnVfLmOzjG0Z/M4pxjQBGPKMMBuOPw/pTtnlhwd3HRiMDPr9KTiF7/ABDY0b7MFd0QjgAnGaeIXeEIqMrpkbwQDn2Jpjo4cSDAOPlUAgH3zU5VjHkli+c4Y5A98n1pWHFdWFsr+WuEI4wckHJq2Is7duxXI69PrimwKwBG4dchg2cH0ParULM8hMZBQ+45P1rORpZM82Tw/a+UqTrs3JnBHRx2qaDwzCdhkwr/AHflUjZ9MdQeua9Cl0wRoZ7q4jV3O1kR9oA9QOuRUbLGuGkdFfO2RVlwrAj7xHbNL6tRe6B15291nBTeHoLd0Ym4gk3YUliuPw5BFRXWg3bANa3srozbDhSuDj0Pau81G5hikEsjwtKG2nypeowOffj+VUjc2bTp5zy75GYSKjfKw7Y4zzxUSwWHlvFFLEVVd3ZxjaFd5j3XFyZTwAr4wR7Y4p1toEjv+8vrhhIeFEjKQR1XpyT6120eq2UZUPZyqGyG8k/K2Ohye+aVtZ050GLW9eXGSFYKrHOc5OcY+lJYPDR6If1uvbW5x03hmzMmXScBuRukYlx6H3FSHwjZsCIrWSVmG5VkdwFUdc88H866KbVrhuEtyFI3AZLKhznjPv8ApUTaxqkszpGi7SQwBiyA2c5H+FW6VBfZX3E81du9395jQ+DrHy2klidPlyMO7KOeoxzxVlPB2nlvOWDzs5bc4fY/qvBHNa73Ws798twFfBZVVVU88HgVVMWprHgXEwVhkKp2hKFCivsIUqlZ6uRQn8EaX5QMUckTlQ6sATnnOOT1H0rPvfDKwgPZXICMu4id94Azjt8wxj3rWEFxLIxdmkwpOSSSPU/Sli0+Z4ZW5ZtnK46L61M8PRqRs4AqlaLup7GF5MtswT7PYzptyJIp8L9ORmpDPNFGXiihCYBG25Y8d+AvWtr7B+5jCkjPBUYyfentpW8BmLIF4weprk/sqg3e34nZ/aFVbs55n1iImewu40Kn1bGPcHr+VS3GseKXiKyXcDc8ALjI9RW5JpsCsfPWQFh8oxk49c0n2RcoPJcnG0EDIH/1qv8AsuhfYX1+tHqYQvNeUFxdQbj1O5z+lPi1nxDCMLKORk+XclfofmFb6W8SwcKqsQQhHODnnj/GlWFYYVMgj2LngDLH1P09qJZVh5apBHMa+1zGi8WeJARn7QCTx+9Rhn3yK0rfx34jjyJtPadevzFRx9QasfZVkwpcAEcKB82MdeP/ANdV5IV3jaxKj5VK9fr7Vk8nw8nqjWOa4mKFi+JMu+Q3mkXyA/KTGm8D88Vct/iJo0gUSXU8DqcbZY2B/MZ/WqMkRYlMSZJ2sf8A6465qJLSd4TFmR0LFTuQNn26VzzyCjL4ZW+RvDPK6XvJHRp4y0aWZgmpWwjfByZAvzfjippPG+mwxJK+p2h2EqQkoYkH0AzXIR6JZOixi1jOThV8oMc9z0zj2qWHSoIVCR28EQbq2Aoas1w8r6zN/wDWCX8puy+PI5UVdJtru7DHAYDyowT2LN/QVkXWr67ezMFvY7WLP3LVNzAehdv5gU8wlbfeFUtHwDnkgdxnr9BV4Q7CDgLCOQqjLDIzuH/1/pXfh8mw9LVrm9Tz8Rm9erpflXkYUGkwLMZJGEsw5aSVvMJ98nt9KvxBDE6oCB5fTBA9yMcEe1Wo9kkwBlDKD945IX3zUkir5+XTrnDK2eDzkDjFepGCgrJHnTm52lJtkC6fJmMIJCXX90xG3I9qApQkyoJEP3cgde568GrscCmNc75Q55Dbgj59C3f2FPhtSuFSFxGASm9NobHGOOKq7M3ZblB4wqqZUUDhmVmGMDoDgGlkhQuzeTklQCMj5fr7ehFT7IYBlo5Hd8HDLtA9cmrbwTSIMh2+U4dQBuHYFfQ+op7alJpptMoRwJGh+z/KS26QLFge3zZ/z1pr3MmQDdTZQ7gCR+Q43Z96sTRxhAsqucKWOQNxPoD6ippjCI0QwSu5QMNq5Mij1wOKaMnJdDMGSQFyV6sjgHzGP86qS2G2eQ3EcEhAC72hUj8cjn610IMcTpviURsFO/HKjsVP86r3ckUWWEdtyc/vAQ49uuCKVk3sVd69zOOk2/7vybS3LsAi7UUsDn/ZxQbdkjKEuApwQDgD2Hv9a1IkjeBWYSCMDYoMYCqfdu4/lTZII2Xy0BBJxt5GPx/qaVkti+bS5QZyqZy23glSCyqPc9FpsQeWKSVkYheeW2H6A/SraRQeQdozt4LFSVPoCO+DULZ8tUDuBjIUnBA/2R2olYcL31Ym6OPHlZJfPzKMbR2z7VJ5YnIVz82Pu4IKj+tQxQ7pVUMgKt8pzjj3Pf6VoiAMWadQSB0Cnr+B4JqW0g+0UYmWKdurZOSMbsVZVyu4MXJ+8CSvHv64+tTSrdwReYjiOLoB0wfrg0gtnyCG3qDwQQeD6Z607iilewsaoEMYiuEjB5EzBhnsQev4iowy78MFYjJJY7yR6g9vpVqW0m88DccouNuRkfj6Yo+x+SFG4qWJ2jj8TikVKKRVaJJFXcM5bcSY+G9wD3qQWwU7l+d3wVBjIJPp7VYcbmSMsgBOPv5Lfh2NSQwsn70+Vg/KE8zkgdvUfhQT11RVgtSOMjL9FC8nmgxOIjvjxnke/PHHrWi8DRbgoBDc7VkCnHpnuaj2yMAIy6spJyrgYPryDk9sVN7FNdSnGMsSAFIxwc4x/sg0xkCMzbSzY43yH9BWiszKrq/mt3IjALHjg+wqOSWbZjaqlDkLgFue5zSuFr6IgVQE4Ryfvjphf61asZmc8YXJyQO/07imJvUbkAkceq5x/hUtusiooYg+pK5YfX2qZWsNavU5rUP+PlP95v5CppP9V+VFFR2No/CiseifSny/8hWL/dSiikviQ+r9AuP9ef8AfNMt/vD/AHT/ADoopL4SPsov/wAR/wBytWL/AJZ/71FFXEH8ZNP/AMe8n/XQUX3/AB8r/uLRRWnQw7/IrXHSH/dNVZPv2f8AwL+RooquqKn+hFc9F/36luP+PY/7/wDWiimugpbodYf62b/ro39Kaf8AWj8aKKRfQrw/61P99v5VHc/62P6n+lFFBPUY3/Hp/wADotv9T/21/pRRVLYqp/X3Fj+Ob/eFNi/1S/8AXU/yoopxOfqy1pH/AB+t/vf+yiq8v+tn/wCBfyooqhv9AH3bL/eNS3P/AB6Q/wDAv50UVLCfQsT/APIMtf8Afb+dOuf+Qfp/1f8ApRRSZctmQS/60f70X9adaf626+q/+h0UUkRMiv8A/Xyf77fzFF//AMe11/13H8zRRVS2RMdn/XQtD/j9h/D+VTp/rIfo39KKKlbI26Ek3W5+hrPg/wCPS4/692oorT7IP4l6k2l/8g+L/rgKkvP+PaP/AK5miip6kyKj/wCoH0P8hWfbf6tvq/8AOiilLcmO8f66j7P7kf0NXE+6PpRRUS3NH+rJ4/8Aj9i/3hVnUv8AWXP+7/Siiq6Frcitf+QY3+e1MHS3/wCuooopLqZMjvf9afr/AFFTx/69PqKKKlBH4mNH3m/3zVmT/j3b/f8A60UVMuhS3ZBYf6u4+gpo/wBZJ9aKKplLYfYf8faVO3+tuvqKKKye5rDc/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Resisted thumb abduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 201px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Resisted thumb extension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 334px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Resisted thumb flexion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 337px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Resisted thumb opposition",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the photograph above, the clinician is trying to disrupt the circle formed by the patient's fingertip and opposing thumb-tip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37994=[""].join("\n");
var outline_f37_6_37994=null;
var title_f37_6_37995="Allo SCT in CR2 ALL";
var content_f37_6_37995=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F57938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F57938&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Leukemia-free survival after allogeneic stem cell transplantation for adult acute lymphoblastic leukemia in second or greater complete remission",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Study",
"       </td>",
"       <td class=\"subtitle1\">",
"        Number of patients",
"       </td>",
"       <td class=\"subtitle1\">",
"        Probability of relapse, percent",
"       </td>",
"       <td class=\"subtitle1\">",
"        LFS at &gt;3 years, percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IBMTR, 1989",
"       </td>",
"       <td>",
"        208 (high risk)",
"       </td>",
"       <td>",
"        56",
"       </td>",
"       <td>",
"        22 (4 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IBMTR, 1989",
"       </td>",
"       <td>",
"        97 (standard risk)",
"       </td>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        36 (4 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Barrett, AJ, 1989",
"       </td>",
"       <td>",
"        391",
"       </td>",
"       <td>",
"        52",
"       </td>",
"       <td>",
"        26 (5 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Gratwohl, A, 1990",
"       </td>",
"       <td>",
"        348",
"       </td>",
"       <td>",
"        NR",
"       </td>",
"       <td>",
"        32",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Blume, KG, 1990",
"       </td>",
"       <td>",
"        49",
"       </td>",
"       <td>",
"        41",
"       </td>",
"       <td>",
"        46",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wingard, JR, 1990",
"       </td>",
"       <td>",
"        36",
"       </td>",
"       <td>",
"        26",
"       </td>",
"       <td>",
"        43 (5 years)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Doney, K, 1991",
"       </td>",
"       <td>",
"        48",
"       </td>",
"       <td>",
"        64",
"       </td>",
"       <td>",
"        15 (5 years)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     All series except IBMTR include both children and adults.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37995=[""].join("\n");
var outline_f37_6_37995=null;
var title_f37_6_37996="Main bone morphogenic";
var content_f37_6_37996=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F75006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F75006&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=9\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Main bone morphogenic proteins and noncollagenous bone matrix proteins and genes involved in vascular calcification in animals and humans",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Protein",
"       </td>",
"       <td class=\"subtitle1\">",
"        Function",
"       </td>",
"       <td class=\"subtitle1\">",
"        Vascular calcification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteopontin",
"       </td>",
"       <td>",
"        Antiapoptotic signal for osteoclasts; chemotactic factor for MC and MP",
"       </td>",
"       <td>",
"        Recruitment of MP into area of vessel injury; osteopontin knockout mice develop stronger skeleton; osteopontin restrains mineralization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Osteoprotegerin/RANKL",
"       </td>",
"       <td>",
"        Inhibitor of osteoclastogenesis; member of tumor necrosis factor-&alpha; receptor superfamily",
"       </td>",
"       <td>",
"        OPG inhibited by cyclosporine A; OPG inhibited by osteopontin; restrains mineralization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Matrix GLA protein",
"       </td>",
"       <td>",
"        Expressed in chondrocytes and vascular smooth muscle cells and increased expression in lipid-rich plaque",
"       </td>",
"       <td>",
"        Knockout mice get dramatic early vascular calcification; warfarin effect on gamma-carboxylation (as osteocalcin); potent inhibitor of mineralization; inhibits bone morphogenic protein-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parathyroid hormone (PTH) recombinant protein",
"       </td>",
"       <td>",
"        Paracrine factor with potential humoral activity in hypercalcemia of malignancy; shares PTH1 receptor with PTH; involved with normal bone physiology",
"       </td>",
"       <td>",
"        Upregulated expression by vessel injury and angiotensin II; antagonizes procalcifying effect of vitamin D3; down-regulates bone morphogenic protein-2",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone morphogenic protein-2",
"       </td>",
"       <td>",
"        Osteoblastic and mesenchymal differentiation",
"       </td>",
"       <td>",
"        Promotes ossification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bone morphogenic protein-7",
"       </td>",
"       <td>",
"        Differentiation factor; normal tubular epithelial differentiation; osteoblastic differentiation",
"       </td>",
"       <td>",
"        Null mouse has renal failure and agenesis; reverses heterotopic calcification in animal models",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vitamin D",
"       </td>",
"       <td>",
"        Diverse functions through vitamin D receptor-dependent and independent pathways",
"       </td>",
"       <td>",
"        Medial calcification; vascular smooth muscle cells have vitamin D receptors; raised calcium-phosphate product",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fetuin",
"       </td>",
"       <td>",
"        Synthesized in liver; soluble transforming growth factor-&beta; antagonist; negative acute phase reactant",
"       </td>",
"       <td>",
"        Knockout mice get ubiquitous soft tissue and vascular calcification; potent inhibitor of mineralization",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pyrophosphate",
"       </td>",
"       <td>",
"        Naturally occurring inhibitor of calcification",
"       </td>",
"       <td>",
"        Loss-of-function mutations that result in decreased pyrophosphate cause idiopathic infantile arterial calcification",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MC: monocyte; MP: macrophage; OPG: osteoprotegerin; RANKL: receptor activator of NF kappaB ligand.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goldsmith D, Ritz E, Cvic A. Vascular calcification: a stiff challenge for the nephrologist: does preventing bone disease cause arterial disease? Kidney Int 2004; 66:1315. Copyright &copy; 2004 Blackwell Publishing.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37996=[""].join("\n");
var outline_f37_6_37996=null;
var title_f37_6_37997="Diagnostic approach in suspected rickets";
var content_f37_6_37997=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F79880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F79880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diagnostic approach in suspected rickets",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 449px; height: 265px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Rickets is suggested by typical clinical signs and elevated alkaline phosphatase activity in a child who has normal kidney and liver function. Calcipenic rickets is sometimes termed \"hypocalcemic rickets,\" but this term is not completely accurate because serum calcium is not always low in this disorder.",
"    <div class=\"footnotes\">",
"     Pi: inorganic phosphorus; PTH: parathyroid hormone; Ca: calcium.",
"     <br/>",
"     * Hypophosphatasia usually is accompanied by low serum alkaline phosphatase activity.",
"     <br/>",
"     <span class=\"bullet\">",
"      &bull;",
"     </span>",
"     The diagnosis of calcipenic rickets should be confirmed by monitoring response to therapy.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37997=[""].join("\n");
var outline_f37_6_37997=null;
var title_f37_6_37998="Dynamic hyperinflation asth";
var content_f37_6_37998=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F78052&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F78052&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dynamic hyperinflation in status asthmaticus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 222px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the normal lung or lungs with decreased lung compliance (eg, acute respiratory distress syndrome, ARDS), the end-expiratory lung volume quickly returns to functional residual capacity (FRC) via passive expiration. However, in patients with airway obstruction due to obstructive lung disorders, such as status asthmaticus, expiration time (te) is increased and the lungs take longer to reach FRC. In patients with obstructive lung disorders, the lung volume at end-inspiration (V",
"    <sub>",
"     EI",
"    </sub>",
"    ) can progressively rise when ventilatory straregies increase inspiratory time (ti) (eg, generous tidal volumes (V",
"    <sub>",
"     T",
"    </sub>",
"    ), low inspiratory flow rates) or shorten te (eg, higher respiratory rates), a phenomenon known as dynamic hyperinflation. The volume of trapped air (V",
"    <sub>",
"     trapped",
"    </sub>",
"    ) above FRC rises at end expiration during dyanamic hyperinflation.",
"    <div class=\"footnotes\">",
"     ARDS: acute respiratory distress syndrome; FRC: functional residual capacity; te: expiration time; V",
"     <sub>",
"      EI",
"     </sub>",
"     : volume at end-inspiration; ti: inspiratory time; V",
"     <sub>",
"      T",
"     </sub>",
"     : tidal volumes; V",
"     <sub>",
"      trapped",
"     </sub>",
"     : volume of trapped air.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Tuxen, DV. Permissive hypercapnic ventilation. Am J Respir Crit Care Med 1994; 150:870 Official Journal of the American Thoracic Society. Copyright &copy; 1994 American Thoracic Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37998=[""].join("\n");
var outline_f37_6_37998=null;
var title_f37_6_37999="Radiocarpal joint line pain";
var content_f37_6_37999=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F72283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F72283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Radiocarpal joint line tenderness",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 315px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wrist is placed in a neutral position. The ulnar styloid is identified (x) and the extensor tendon of the index finger is identified (arrows). The scaphoid (navicular) is palpated at the intersection of the distal radius and the extensor tendon. The lunate is palpated between the ulnar styloid and the scaphoid bone. Tenderness may be enhanced by passively flexing and extending the wrist in an arc of 50 degrees.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f37_6_37999=[""].join("\n");
var outline_f37_6_37999=null;
